Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2025 Aug 22;21(8):e1011691. doi: 10.1371/journal.pgen.1011691

Analysis of (p)ppGpp metabolism and signaling using a dynamic luminescent reporter

Molly Hydorn 1, Sathya Narayanan Nagarajan 1, Elizabeth Fones 2, Caroline S Harwood 2, Jonathan Dworkin 1,*
Editor: Jue D Wang3
PMCID: PMC12373219  PMID: 40845056

Abstract

As rapidly growing bacteria begin to exhaust nutrients, their growth rate slows, ultimately leading to the non-replicative state of quiescence. Adaptation to nutrient limitation requires widespread metabolic remodeling that is in part mediated by the phosphorylated nucleotides guanosine tetra- and penta-phosphate, collectively (p)ppGpp. We have developed a novel reporter of (p)ppGpp abundance in the Gram-positive bacterium Bacillus subtilis based on the recent identification of a riboswitch that binds (p)ppGpp and modulates transcription via regulation of a transcriptional terminator. Placement of an unstable reporter, firefly luciferase, downstream of the riboswitch allows for sensitive and dynamic assessment of (p)ppGpp. We first confirm that the reporter accurately reflects (p)ppGpp abundance in a variety of well-established conditions. We then proceed to use it to demonstrate the physiological importance of several mechanisms of regulation of (p)ppGpp metabolism previously observed only in vitro including allosteric interactions between (p)ppGpp synthesis enzymes and the hydrolytic activity of a (p)ppGpp synthetase. (p)ppGpp signaling has been implicated in the regulation of gene expression, and we demonstrate a close temporal association between gene expression and (p)ppGpp abundance, indicating a rapid, and therefore likely direct mechanism of (p)ppGpp dependent gene activation. Thus, this reporter provides a new, comprehensive analysis of (p)ppGpp signaling in vivo and offers the potential ability to sensitively monitor the temporal dynamics of (p)ppGpp abundance under diverse environmental conditions.

Author summary

Most bacteria adapt to stressful conditions such as nutrient limitation by synthesizing a signaling molecule, known as ppGpp, that consists of a hyper-phosphorylated GTP. Synthesis of ppGpp affects most aspects of cellular physiology including replication, transcription and translation. We present here a method that allows measurement of ppGpp abundance in living cells, greatly facilitating investigation into ppGpp metabolism.

Introduction

The adaptive response of bacteria to environmental changes can be relatively specific, as in the case of two-component signaling that involves a single transcription factor regulating a limited number of genes. Alternatively, an adaptive response can be broad, such as the widespread physiological changes often referred to as the “stringent response” mediated by the nucleotides guanosine tetraphosphate (ppGpp) and pentaphosphate (pppGpp), collectively (p)ppGpp. These molecules reduce replication, transcription, translation and GTP synthesis by direct inhibitory interactions with essential enzymes of these processes [1,2]. They also stimulate the expression of genes encoding proteins mediating stress protection (e.g., B. subtilis hpf [3]), but the mechanistic basis for this stimulation is not well understood.

In both Gram-positive and Gram-negative bacteria, RelA/SpoT Homolog (RSH) enzymes [4] synthesize (p)ppGpp in response to diminished amino acid availability as manifested by the presence of uncharged tRNA molecules in ribosome A-site [5]. RSH enzymes contain a synthetase domain that transfers the β- and γ-phosphate groups from ATP and adds them to the 3’ hydroxyl of the ribose of a GTP or GDP molecule to form pppGpp or ppGpp, respectively [6]. In Gram-positive species, Small Alarmone Synthetase (SAS) proteins, which have homology to the synthetase domains of RSH proteins [4], also produce (p)ppGpp [7] in a non-ribosome dependent fashion.

Extensive amino acid contacts with the ribosome mediate the regulation of RSH-dependent (p)ppGpp synthesis in response to amino acid availability [810]. Additionally, the RSH proteins E. coli RelA [11] and B. subtilis Rel [10] are allosterically activated by pppGpp binding. Allostery is also observed with the B. subtilis SAS SasB, where mutation of a single residue prevents allosteric stimulation in vitro [12,13]. Introduction of this mutation into the chromosomal copy of sasB mimics a ∆sasB mutation in the context of the regulation of protein synthesis [13]. However, the overall role of allostery in the regulation of (p)ppGpp metabolism in vivo is not well characterized.

Many RSH enzymes also exhibit hydrolase activity that converts pppGpp and ppGpp into GTP and GDP, respectively [6]. By comparison with (p)ppGpp synthesis, regulation of RSH-dependent (p)ppGpp hydrolysis is less well understood. In E. coli the RSH protein SpoT serves as the primary hydrolase and strains expressing a hydrolysis-deficient spoT mutant display increased (p)ppGpp abundance during a diauxic shift [14]. SpoT hydrolysis activity is regulated by protein-protein interactions with various proteins [1517]. Most RSH proteins contain a small molecule binding domain (ACT) and the binding of branched chain amino acids to ACT can stimulate (p)ppGpp hydrolysis in R. capsulatus, but the generality of this mechanism is not known [18]. In addition, some bacteria contain so-called Small Alarmone Hydrolase (SAH) enzymes capable of hydrolyzing (p)ppGpp [4] but their regulation is not well understood.

RSH enzymes, particularly those of the RelA/SpotT/Rel class, exhibit a functional coupling of synthetase and hydrolytic activities, mediated, at least in part, by pppGpp-dependent allosteric regulation and also fundamentally by the aminoacylation state of the tRNA in the ribosome A site. [1921]. Thus, under conditions where the population of tRNAs is partially aminoacylated [22], RSH enzymes would likely oscillate between synthetase and hydrolase activities resulting in changes in (p)ppGpp abundance during growth. Such a mechanism could underlie the proposed ability of (p)ppGpp to act as a reversible brake on growth [23]. In fact, during strong heat shock, the abundance of (p)ppGpp increases quickly (within 2 min) but is substantially dissipated by 15 min [3]. Existing methods of measuring (p)ppGpp abundance including radiolabeling of cells with 32P-ATP under low phosphate conditions followed by analysis of cell extracts by thin layer chromatography (TLC) or liquid chromatography/mass spectrometry (LC/MS) analysis of lysates (e.g., [2427]) are relatively cumbersome and are not optimal techniques for conditions such as growth that may require both temporal sensitivity and physiological robustness.

Here, we use a (p)ppGpp-sensitive riboswitch [28] in conjunction with firefly luciferase (luc), an unstable reporter with a half-life in B. subtilis of ~5 min [29], to serve as a dynamic sensor of (p)ppGpp abundance. We use this sensor to directly demonstrate the roles of the hydrolytic activity of the RSH protein Rel and allosteric regulatory sites in both Rel and a SAS protein in governing changes in (p)ppGpp abundance during physiological contexts including nutrient exhaustion and amino acid downshifts. In addition, we demonstrate that (p)ppGpp synthesis closely coincides with the expression of genes under (p)ppGpp control, indicating that this regulation is rapid and likely direct.

Results

We placed a sequence corresponding to the (p)ppGpp-sensitive riboswitch from the promoter of Desulfitobacterium hafniense ilvE [28] between an inducible promoter (Phyperspank) and the luc gene encoding firefly luciferase (luciferin 4-monooxygenase) (RsFluc; Figs 1A and S1). This construct was integrated at the sacA locus and luminescence measurements were performed during growth in S7/glucose defined medium in a microplate reader. Raw luminescence readings were normalized to OD600 (RLU/OD) (Fig 1B, blue). We observed two waves of luminescence, one just after initiation of growth and then a second larger one during early transition phase, near the time of departure from the most rapid period of growth. While the time and magnitude of the second wave (~220 min) was robust across numerous biological replicates, the first wave was much more variable, possibly as a result of the proximity to the culture dilution performed at the initiation of the experiment. Both waves were dependent on the presence of the riboswitch in the reporter construct as a reporter (RsFluc0) lacking the intervening riboswitch sequence exhibited greatly reduced luminescence (S2A Fig). The residual response suggests that (p)ppGpp may be also stimulating transcription initiation from Phyperspank.

Fig 1. RsFluc (p)ppGpp-sensitive firefly luciferase reporter.

Fig 1

A, schematic of the (p)ppGpp reporter RsFluc depicting the inducible promoter Phyperspank fused to the (p)ppGpp-senstive riboswitch of D. hafniense ilvE followed by the gene encoding firefly luciferase. B, luminescence (RLU/OD600) of RsFluc (blue; JDB4496), mutant RsFlucmut (green; JDB4631) in wildtype backgrounds and RsFluc in a ∆relAsasAsasB background (red; JDB4512), C) ppGpp concentration determined by HPLC-MS (black closed circles) and corresponding reporter luminescence corrected for (p)ppGpp0 luminescence by subtraction (blue open circles). D, luminescence per OD600 of RsFluc (black), RsFlucnatA (purple, JDB4730) and RsFluclivK (cyan, JDB4731). Shown are representative examples of at least three biological replicates, each comprising three technical replicates.

An RsFluc-expressing strain carrying deletions in the gene encoding all three B. subtilis (p)ppGpp synthetases (relA, sasA, sasB; (p)ppGpp0) exhibited a significantly attenuated luminescence (Fig 1B, red), consistent with the expectation that the signal reflects (p)ppGpp abundance. In addition, we constructed mutant RsFluc reporters containing two previously characterized riboswitch mutations [28], one that decreases sensitivity to (p)ppGpp as the binding pocket has been disrupted (M9) and a second that strengthens the terminator (M11), thereby increasing the specificity of the response (S1 Fig). Reporters containing either mutation exhibited reduced luminescence (S2B, S2C Fig) and a reporter containing both (RsFlucmut) was substantially attenuated (Fig 1B, green). As these mutations are not known to completely prevent (p)ppGpp binding, consistently, this effect is less strong than in the (p)ppGpp0 background, which may exhibit some secondary physiological effects resulting from the absence of the signaling molecule, particularly in transcription and translation [1,2].

As a further confirmation of the reporter, we measured (p)ppGpp by LC/MS at points in the growth curve with different RsFluc activities. Values were normalized with respect to OD600 and to a parallel measurement in a (p)ppGpp0 strain, resulting in lower (p)ppGpp before and after the time of the luminescence peak (Fig 1C). Calculation of the absolute concentration of (p)ppGpp yielded an estimate of ~60 nM/OD600 (S3A Fig). Of note, we observed only modest declines in GTP (S3B Fig). Additionally, we confirmed that the RsFluc reporter signal is accompanied by changes in transcriptional readthrough by fluorescent in situ hybridization (FISH) of the mRNA of a reporter gene downstream of the riboswitch. Approximately 10 minutes after the observed increased transcription at TP3 (S4B Fig), the RsFluc signal reaches maximum (S4A Fig). Transcription rates fall to basal levels in the subsequent timepoints (S4B Fig) and RsFluc signal decreases (S4A Fig). Taken together, these results and those described above demonstrate that RsFluc activity reflects changes in (p)ppGpp abundance.

As noted above, (p)ppGpp refers collectively to ppGpp and pppGpp. The D. hafniense ilvE riboswitch has no in vitro preference for binding pppGpp or ppGpp [30], suggesting that RsFluc is equally sensitive to both molecules in vivo. Aptamers with preference for pppGpp or ppGpp have been identified [30]. For example, the Clostridiales bacterium natA aptamer exhibits a ~ 10-fold preference for pppGpp as compared to ppGpp whereas the Oxobacter pfennigii livK aptamer exhibits a ~ 6-fold preference for ppGpp [30]. We constructed versions of the RsFluc reporter containing these aptamers in place of D. hafniense ilvE, RsFlucnatA and RsFluclivK, respectively. The similarity between RsFluc and the ppGpp sensitive reporter RsFluclivK (Fig 1D) is consistent with previous observations that the abundance of ppGpp > pppGpp [31]. In addition, the pppGpp sensitive reporter RsFlucnatA exhibited a delayed expression in comparison to the other reporters (Fig 1D).

We then characterized the effect on RsFluc activity of perturbations that stimulate in vivo (p)ppGpp synthesis. As uncharged tRNAs activate RelA-dependent (p)ppGpp synthesis [5], many such perturbations affect aminoacyl-tRNA charging. One example is a culture grown in amino acid-replete medium shifted to a medium lacking amino acids, which is a transition that reduces aminoacylation [32] and stimulates (p)ppGpp synthesis [33]. Consistently, a spike in RsFluc activity occurred shortly (~30 min) after the down-shift (Fig 2A, black) that is attenuated in strain expressing the RsFlucmut reporter. The timing of this response illuminates the temporal relationship between our reporter and (p)ppGpp abundance. Amino acid starvation results in rapid diminution of tRNA charging (~5 min, [34]) and increased ppGpp synthesis (~10–15 min [35]). The difference between these values and that which we observe with RsFluc suggests that activation of the riboswitch and subsequent expression of the firefly luciferase together take <20 min.

Fig 2. RsFluc reporter response to stimulation of (p)ppGpp synthesis.

Fig 2

Luminescence (RLU/OD600) of: A, RsFluc (black; JDB4496) and RsFlucmut (blue; JDB4631) after amino acid downshift at T60 (dashed line); B, RsFluc (black) and RsFlucmut (blue) after 0 and 60 mins of 50 ng/mL mupirocin treatment. Significance was determined by two-tailed t test: p-value < .05 for RsFluc, no significant difference for RsFlucmut; C, RsFluc grown in defined minimal media containing either 2.5 mg/mL of glucose (black) or 0.5 mg/mL glucose and 2.0 mg/mL arabinose (blue). Respective OD600 measurements are shown in grey and light blue, respectively, and D) RsFluc (black) and a PpurE luciferase promoter fusion in wildtype (orange; JDB4803) and (p)ppGpp0 (purple; JDB4804) backgrounds. Shown are representative examples of at least three biological replicates, each comprising three technical replicates.

Inhibitors of tRNA synthetases serve as an alternative strategy to modulate tRNA charging. For example, mupirocin, an inhibitor of isoleucyl-tRNA synthetase [36] stimulates (p)ppGpp synthesis [37]. Consistently, RsFluc-expressing cells treated with mupirocin exhibited a significant increase in luciferase production not observed in cells expressing the (p)ppGpp-insensitive RsFlucmut reporter, indicating that the effect was specific to changes in (p)ppGpp abundance (Fig 2B). We investigated the mupirocin concentration causing the maximal stimulation of RsFluc activity, observing that 100 ng/ml was less effective than 50 ng/ml (S5A Fig). The severe diminution of growth in the presence of 100 ng/ml mupirocin (S5B Fig) suggests at this concentration, the mupirocin is having physiological effects beyond (p)ppGpp synthesis such as direct inhibition of protein synthesis.

Both direct (32P-radiolabeling) [14] and indirect (transcriptional profiling) [38] assays observe (p)ppGpp synthesis during a diauxic shift when bacteria adapt to grow on a secondary carbon source following glucose exhaustion. We measured RsFluc activity during a diauxic shift from glucose to arabinose as the only carbon sources (e.g., without amino acid supplementation) following a protocol [29] based on the original Monod B. subtilis observations [39]. The transient flattening of the growth curve in the culture grown in 0.5 mg/ml glucose & 2.0 mg/ml arabinose is characteristic of a diauxic shift and is accompanied by prominent spike in RsFluc activity at ~240 min indicative of a substantial increase in (p)ppGpp abundance (Fig 2C, blue). In contrast, growth in 2.5 mg/ml glucose (black) did not result in substantial changes in either growth or luciferase.

As an additional confirmation that RsFluc activity reflects (p)ppGpp abundance, we monitored expression of a firefly luciferase fusion to the purE promoter that is sensitive to (p)ppGpp levels [40]. Specifically, (p)ppGpp enhances PurR DNA binding, thereby increasing repression of purE transcription. Consistent with previous observations [40], PpurE-luciferase activity was affected by the absence of (p)ppGpp (Fig 2D, compare orange and purple). We observed lowest PpurE-luciferase (orange) activity at approximately the same time as RsFluc (black) activity increased (~180 min) and a later rise in PpurE activity when RsFluc was diminishing. Taken together, these data support the interpretation that RsFluc activity reflects (p)ppGpp abundance.

We then investigated the source of the (p)ppGpp responsible for the RsFluc signal. B. subtilis RelA, SasA (RelP), and SasB (RelQ) are the known (p)ppGpp biosynthetic enzymes [7,41]. Consistently, an RsFluc-expressing strain lacking all three proteins (∆relAsasAsasB) exhibits substantially reduced luminescence compared to the wild type parent (Fig 1B). We investigated the contributions of each protein to RsFluc activity by assaying cells carrying single mutations in their respective genes under growth (Fig 3A, see S6 Fig for corresponding growth curve) and amino acid downshift (Fig 3B, see S8 Fig for corresponding growth curve). While all three mutations affected expression during growth, a strain lacking RelA synthetase activity due to an inactivating point mutation (D264G) in the synthetase domain [7] exhibited the largest effect (blue, Fig 3A), essentially indistinguishable from the triple mutant ∆relAsasAsasB strain (red). In contrast, single ∆sasA (green) or ∆sasB (orange) or the combination ∆sasAsasB (S7 Fig, brown) mutant strains exhibited at most only modest delays in RsFluc signal. During amino acid downshift, the relA-D264G strain was again severely affected, but under these conditions, the ∆sasAsasB strain was similarly defective (blue, brown; Fig 3B).

Fig 3. Relative contributions of (p)ppGpp synthetases to dynamics of RsFluc activity.

Fig 3

Luminescence (RLU/OD600) of: A, RsFluc in wildtype (black, JDB4496), ∆relAsasAsasB (red, JDB4512), ∆sasA (green, JDB4515), ∆sasB (orange, JDB4516), and relA-D264G (blue, JDB4741) backgrounds and B), wildtype (black), ∆sasA (green), ∆sasB (orange), ∆sasAsasB (brown, JDB4511), and relA-D264G (blue) strains after amino acid downshift at T60 (dashed line). Shown are representative examples of at least three biological replicates, each comprising three technical replicates.

RsFluc activity in the ∆sasB strain was strikingly different as compared to the wildtype parent in the context of nutrient downshift (Fig 3B). What underlies this effect? In vitro, SasB is activated allosterically by pppGpp produced by Rel [12]. SasB Phe-42 is a key residue in this regulation and a SasB mutant protein carrying an F42A substitution is no longer allosterically activated in vitro by pppGpp [12]. RsFluc activity of a strain carrying a sasB-F42A allele in the chromosome [13] was delayed both during growth (Fig 4A, blue) and nutrient downshift (Fig 4B, blue). Thus, this delay is the result of the absence of SasB stimulation. Rel itself is subject to allosteric regulation in vitro by pppGpp [10], and Tyr-200 is important for this effect [19]. Introduction of a Rel Y200A mutation into the chromosomal copy of rel delayed the increase in RsFluc activity during growth as compared to the wildtype parent strain (Fig 4A, purple). During a nutrient downshift (as in Fig 3B), this mutation also delayed increased RsFluc activity (Fig 4B, purple). Importantly, the magnitude of the increase was not substantially affected, indicating that Rel Y200A likely does not impair synthetase activity during nutrient downshift. Thus, taken together, these observations provide the first evidence of the in vivo function of allosteric regulation in (p)ppGpp metabolism.

Fig 4. RsFluc activity coordinated by allosteric network.

Fig 4

Luminescence (RLU/OD600) of: A, RsFluc in wildtype (black, JDB4496), relA-Y200A (fuschia, JDB4528), and sasB-F42A (blue, JDB4711) strains and B, RsFluc in wildtype (black), relA-Y200A (fuschia), and sasB-F42A (blue) strains after amino acid downshift (dashed line). Shown are representative examples of at least three biological replicates, each comprising three technical replicates.

Regulation of RSH enzymes is not limited to direct effects on their biosynthetic activity as many RSH enzymes including Rel also hydrolyze (p)ppGpp, thereby indirectly antagonizing the synthetic activity. Investigating the contribution of Rel-dependent (p)ppGpp hydrolysis to RsFluc expression is complicated by its essentiality in the presence of any (p)ppGpp synthetases, including Rel itself [41]. Inspired by a previous study [3], we developed a system allowing transient expression of a RelA mutant lacking hydrolytic activity (D78A; [21]) under control of the PliaI bacitracin-inducible promoter [42] (Fig 5A). We first confirmed that expression of an inducible wildtype rel allele complemented RsFluc activity in a ppGpp0 background (compare blue and gray; Fig 5B). Expression of a Rel-D78A mutant protein slowed growth (S11 Fig), consistent with increased (p)ppGpp abundance and produced a broadening of the increased RsFluc activity before and after the peaks seen with expression of wildtype RelA (Fig 5B, red). Another reported (p)ppGpp hydrolase is NahA [43], but a ∆nahA mutation does not affect RsFluc (S12 Fig). Thus, Rel is the primary hydrolase activity affecting the dynamics of (p)ppGpp abundance under our experimental conditions.

Fig 5. RelA hydrolase activity contributes to dynamics of RsFluc activity.

Fig 5

A, schematic of bacitracin-inducible relA constructs. B) luminescence (RLU/OD600) of RsFluc in wildtype (black, JDB4496), ∆relAsasAsasB with PliaI-relA (blue, JDB4675), ∆relAsasAsasB with PliaI-relA-D78A (red, JDB4676) and ∆relAsasAsasB (gray, JDB4512) strains. RelA expression induced by 5 µg/mL bacitracin at T90 (dashed line). Shown is a representative example of at least three biological replicates, each comprising three technical replicates.

The importance of Rel (p)ppGpp synthetic activity for RsFluc expression (Fig 4A) suggests that amino acid abundance is the primary factor determining for stimulating (p)ppGpp synthesis. To test this hypothesis, we examined RsFluc activity as a function of amino acid concentration in the growth medium. Consistently, increasing concentrations of Casamino acids (CAA) delay maximal RsFluc activity (Fig 6A) with minimal effects on growth. In the absence of added amino acids, RsFluc activity was substantially attenuated, especially following departure from exponential growth (Fig 6B). This activity is substantially higher than exhibited by the RsFlucmut (p)ppGpp-insensitive reporter, so it likely reflects actual (p)ppGpp abundance.

Fig 6. RsFluc activity and amino acid availability.

Fig 6

Luminescence (RLU/OD600) of: A, RsFluc in prototroph (JDB4656) cultured in S7 supplemented with 0.005% (blue), 0.01% (black), and 0.02% (green) casamino acids and B, RsFluc (black) and RsFlucmut (blue) in prototroph background without amino acid supplementation. Shown are representative examples of at least three biological replicates, each comprising three technical replicates.

We finally investigated how changes in RsFluc activity correlate with the appearance of known (p)ppGpp-dependent physiological phenomena in B. subtilis including gene activation [44] and protein synthesis attenuation [45]. Specifically, induction of the stringent response by arginine hydroxamate treatment leads to (p)ppGpp-dependent expression of a number of amino acid biosynthetic genes [44]. We constructed firefly luciferase fusions to the promoters of three of these genes (PserA-luc, PilvB-luc, PmetE-luc) and compared their temporal dynamics with RsFluc. All reporters exhibited luciferase activity with very similar temporal dynamics to that of RsFluc (Fig 7A). Consistent with the previous study, presence of a relA-D264G mutation substantially attenuated all reporters (Fig 7B) [44].

Fig 7. Correlation of amino acid biosynthetic gene expression and RsFluc activity.

Fig 7

Luminescence (RLU/OD600) of: A, RsFluc (black, JDB4496), PserA-luc reporter (blue, JDB4759), PilvB-luc reporter (green, JDB4792), and PmetE-luc reporter (red, JBD4798) in the wildtype background and B, reporters as A in the relA-D264G genetic background. Shown are representative examples of at least three biological replicates, each comprising three technical replicates.

The increase in RsFluc coincides with a sharp reduction in growth rate (Fig 8A, black). The linear correlation between protein synthesis (particularly ribosomal proteins) and growth rate [46] suggests that the increase in RsFluc is associated with reduced protein synthesis. To compare the temporal dynamics of protein synthesis and (p)ppGpp, we incorporated OPP (O-propargyl-puromycin) into cells before (S13 Fig, arrow “TP1”) and during (“TP2”) the increase in RsFluc. Click-conjugation of OPP with a fluorophore (Fig 8B, ‘wildtype’) and subsequent quantification revealed OPP labeling substantially declined in the interval from TP1 to TP2 (Fig 8C). Since (p)ppGpp inhibits translation initiation [45], we asked if this change in OPP labeling was dependent on (p)ppGpp. We obtained samples of ppGpp0 cells at the same time points and processed them similarly (Fig 8B, ‘ppGpp0’). In contrast to the wildtype cells, OPP labeling of ppGpp0 cells did not decline between TP1 and TP2, and in fact, it increased (Fig 8D), consistent with the role of (p)ppGpp in attenuating protein synthesis.

Fig 8. Temporal relationship between protein synthesis and RsFluc activity.

Fig 8

A, luminescence (RLU/OD600) of RsFluc (blue, JDB4496) and growth rate (black). Growth rate/hour (µ) at a given time (t) is defined as log2[OD600(t)-OD600 (t-60)]. B, representative composite (fluorescent, phase) images of cells at TP1 and TP2 (see S11 Fig) in either wildtype (JDB4486) or ∆relAsasAsasB (‘(p)ppGpp0’; JDB4512) backgrounds. C) and D) quantification of images from B.

Discussion

Here we develop and evaluate RsFluc, a novel dynamic riboswitch-based reporter of (p)ppGpp metabolism in B. subtilis. We confirm that RsFluc accurately reflects (p)ppGpp abundance using a variety of approaches, including mutagenesis of both reporter and host. In addition, known stringent response inducers such as inhibition of tRNA aminoacylation or a nutrient downshift robustly stimulate RsFluc activity. We use RsFluc to demonstrate the in vivo relevance of mutations that affect allosteric activation of (p)ppGpp synthetases and the involvement of Rel hydrolase activity in (p)ppGpp abundance. Together, these observations demonstrate that RsFluc will serve as an integral component of the experimental toolkit in investigating (p)ppGpp metabolism and regulation. Finally, we demonstrate the temporal dynamics of RsFluc activity correlate with the appearance of known (p)ppGpp-dependent physiological phenomena in B. subtilis including gene activation and protein synthesis attenuation, suggesting that these effects are likely direct.

The importance of Rel, the sensor of amino acid availability (Fig 3A), and the effect of supplemental amino acid concentrations for RsFluc activity (Fig 6A) are consistent with the long-held view that amino acid limitation is the key signal underlying (p)ppGpp synthesis. To further investigate this, we grew a prototrophic strain in the absence of supplemental amino acids where amino acid abundance is limited only by the availability of carbon and nitrogen. We observed no substantial fluctuations in RsFluc activity during growth (Fig 6B) and reduced levels throughout growth. Importantly, the basal level of RsFluc activity is higher than that of RsFlucmut (compare black and blue), indicating that these levels, even if low, are real. This data may be relevant to understanding the role of (p)ppGpp role in contexts sometimes referred to “basal” levels of (p)ppGpp, which are defined as non-stressful growth conditions [23,47,48] such as motility during exponential growth [49] and the coordination of ribosome synthesis to functional tRNA abundance [22,50].

Investigation of (p)ppGpp metabolism in both E. coli [51] and B. subtilis [52] observed a decrease in GTP abundance accompanying an increase of (p)ppGpp abundance consistent with GTP/GDP serving as the biosynthetic precursor. However, similar to E. coli during nutrient limitation conditions [24] or B. subtilis during heat shock [3], we do not observe a similar (negative) correlation (S3B Fig). This discrepancy could be a consequence of differences in the kinetics of activation, as the hydrirocin used in the earlier studies rapidly and strongly stimulates (p)ppGpp abundance in <5 min. Thus, rapid synthesis of (p)ppGpp could deplete GTP/GDP pools before homeostatic mechanisms [53] are able to restore their levels. Alternatively, this discrepancy may reflect the magnitude of changes in tRNA charging: under explicit amino acid starvation, tRNA charging falls to near-zero levels on a time scale of ~min [34], a much more substantial decrease than observed during growth phase transitions [22].

(p)ppGpp has well-characterized global effects [1,2] that could affect RsFluc expression, apart from the riboswitch element, and complicate interpretation of RsFluc activity. However, we believe this is unlikely for two reasons. First, activity of the RsFlucmut reporter, carrying a mutation in the ilvE riboswitch that reduces the in vitro sensitivity to (p)ppGpp [28] is attenuated as compared to the wildtype RsFluc reporter (Fig 1B). This attenuation is similar to that observed with mutant RsFluc reporter lacking the entire RS element (RS0, S2A Fig). Thus, these observations in a wildtype background indicate that a significant effect on luciferase activity can be observed even in a strain wildtype for (p)ppGpp synthesis. Further, these observations are consistent with a stimulatory effect of (p)ppGpp on transcription as we observed (Fig 7). Second, while (p)ppGpp has a clear inhibitory effect on global protein synthesis [45], this effect would tend to dampen the response of a protein reporter such as luciferase thereby minimizing observed (p)ppGpp-dependent increase in RsFluc activity. Thus, this increase (e.g., Fig 1B) is likely less than is actual given the compensatory inhibition of (p)ppGpp on synthesis of luciferase.

Our work confirms the previously reported [7] importance of Rel for (p)ppGpp synthesis during growth (blue; Fig 3A). However, SasA and SasB only modestly contribute to the RsFluc dynamics during transition phase (orange, green; Fig 3A). The absence of a substantial effect of the lack of SasB is surprising given that it is expressed just prior to transition phase and is also a potent producer of ppGpp, at least in vitro or when overexpressed ectopically in E. coli [7]. The lack of an effect of SasA is also surprising given that both SasA is expressed during the transition from exponential growth [54] like RsFluc and that SasA synthesizes ppGpp [27]. NahA may degrade a substantial fraction of the ppGpp to pGpp [43] but the absence of NahA does not have a substantial effect on RsFluc (S12 Fig). To our knowledge, previous studies have not examined the specific synthetase and hydrolase dependency of (p)ppGpp accumulation during B. subtilis growth.

In contrast to growth, sasA and sasB have substantial effects during amino acid downshift (Fig 3B, green, orange), with strains carrying ∆sasA or ∆sasB mutations exhibiting delayed RsFluc expression. In fact, the double ∆sasA∆sasB mutant strain (brown) exhibits greatly attenuated RsFluc activity, similar to the relA-D264G strain (blue). Both strains also exhibit severe growth defects following downshift (S6 Fig, blue, brown), suggesting that all three genes play a key role in the resumption of growth following abrupt starvation, as has been suggested for E. coli RelA [55]. Thus, taken together, our observations provide a starting point for future investigations to understand the regulation of B. subtilis Rel, SasA, and SasB during regrowth.

The role of (p)ppGpp in the phenomenon of diauxie has been studied for >50 years [56]. However, E. coli strains lacking (p)ppGpp exhibit multiple amino acid auxotrophies [57], complicating analysis in a growth medium consisting only of a single carbon source (that is, without added amino acids that can serve as a source of carbon). Similar auxotrophies also have been reported for B. subtilis [38,44]. The experiments presented here demonstrate that (p)ppGpp is synthesized during a diauxic shift in B. subtilis (Fig 2C). Rel is the only (p)ppGpp synthetase necessary for this synthesis as the RsFluc activity of a ∆sasA∆sasB strain is essentially the same as the wildtype parent (S7 Fig). Thus, during glucose exhaustion, the availability of amino acids necessary for charging tRNAs as sensed by Rel is the signal stimulating (p)ppGpp synthesis. Interestingly, Lactococcus lactis exhibits single cell heterogeneity in their ability to react to diauxie [58]. Given that this phenomenon is subject to stringent response control, heterogeneity in (p)ppGpp abundance at the single cell level was proposed to underlie this phenomenon. This intriguing hypothesis awaits the development of (p)ppGpp reporters amenable to single cell analysis.

Allosteric regulation has been observed in vitro for B. subtilis (p)ppGpp synthetases Rel [10] and SasB [12] (but not SasA [59]). Our analysis of strains carrying mutations in residues identified in vitro to be important for this regulation (RelA-Y200A [10], SasB-F42A [12]) reveals that that allostery affects (p)ppGpp abundance in vivo (Fig 4). In addition, while these strains grow equivalently to the wildtype parent (S9 Fig), both exhibit impaired recovery from nutritional downshift (S10 Fig). This is the first time that allostery has been demonstrated to mediate a specific physiological function of the (p)ppGpp metabolic network. Since strains carrying a ∆sasB deletion also exhibit a substantial phenotype with respect to (p)ppGpp synthesis in response to a nutritional downshift (Fig 3B), the phenotype of a sasB-F42A strain with respect to recovery suggests a mechanistic explanation for this phenotype.

The synthetic activity of B. subtilis (p)ppGpp synthetases is well understood to be regulated by interactions with the ribosome (e.g., Rel [21]) or by transcriptional regulation in the case of SasA/RelP and SasB/RelQ [54]). In contrast, the regulation of hydrolase activity, either in the context of the Rel dual synthetase/hydrolase or standalone hydrolases such as NahA is less clear. A difficulty in investigating the in vivo function of Rel hydrolase activity results from its essentiality in the presence of any (p)ppGpp synthetic activity. Our experiments using comparison of a transiently expressed wildtype Rel with a hydrolase-dead mutant (D78A) directly demonstrate that the hydrolase activity of Rel affects the abundance of (p)ppGpp as verified by the RsFluc reporter (Fig 5B). The relative constancy of luciferase expression in the relA-D78A strain as compared with the strain expressing a hydrolase-active allele suggests both that regulation of hydrolysis activity is important in generating the observed spike in ppGpp and that it is not just regulation of the synthetase domain which is important for determining (p)ppGpp abundance. This interpretation is consistent with a recent model of Rel function that envisions a switch between Hydrolase-Active/Synthetase-Inactive and Hydrolase-Inactive/Synthetase-Active configurations [10,21]. This switch could be controlled by ribosome association, but it is not clear what would stimulate a change in this interaction under the gradual nutrient exhaustion investigated here. Alternatively, this could be a consequence of the allosteric regulation of Rel by one of its products [19], as discussed above.

Treatment with a small molecule that reduces tRNA aminoacylation, such as mupirocin, a isoleucyl-tRNA synthetase inhibitor, is a typical laboratory strategy to induce (p)ppGpp synthesis [36]. We observe that mupirocin stimulates RsFluc expression (Fig 2B) but the response is not monotonic, with 50 ng/ml mupirocin stimulating to a greater extent than 25 ng/ml but less than 100 ng/ml (S5A Fig). Given that increased mupirocin results in decreased tRNA charging, which itself inhibits protein synthesis, 100 ng/ml mupirocin could affect protein synthesis sufficiently to interfere with expression of the luciferase reporter. The observation that 100 ng/ml mupirocin affects growth much more substantially than 50 ng/ml (S5B Fig) is consistent with this explanation. Thus, interpretation of the effect of 100 ng/ml mupirocin is complicated by the action of ppGpp to inhibit protein synthesis [45]. Similar issues may be common with other molecules that stimulate (p)ppGpp synthesis by affecting tRNA charging, suggesting that careful titration may be necessary in order to properly control for indirect effects on protein synthesis [60].

The close temporal correlation between the activity of luciferase fusions to the promoters of several amino acid biosynthetic genes with RsFluc (Fig 7A) suggests that (p)ppGpp directly activates their transcription. A fall in GTP levels as a consequence of (p)ppGpp synthesis and the subsequent activation of CodY, a known repressor of amino acid biosynthetic genes is a potential mechanism [44]. However, GTP levels do not significantly fall during the time of RsFluc activity (S2B Fig), similar to that observed when (p)ppGpp and GTP abundances were monitored by HPLC during E. coli growth [24]. Finally, (p)ppGpp binds RNAP and in conjunction with DksA directly modulates transcription of target genes in E. coli [61], but as there is no evidence for a similar interaction in B. subtilis, future research should investigate how such positive regulation occurs.

The use of riboswitches as a basis for physiological reporters of signaling nucleotide abundance is becoming increasingly widespread. Examples include a B. subtilis cyclic-di-GMP reporter [62], a S. aureus cyclic-di-AMP reporter [63], an E. coli (p)ppGpp reporter [64]. These studies utilized a fluorescent reporter and observed changes in fluorescence during growth, although the relative stability of the reporters impaired analysis of dynamics. These metabolites, especially (p)ppGpp, play important roles in the physiology of commensal and pathogenic bacteria. For example, bacteria lacking (p)ppGpp exhibit defects in virulence (e.g., Campylobacter jejuni [65]), Mycobacterium tuberculosis [66,67]) and commensal persistence [68] and colonization [69]. One issue in investigating these phenomena is that assessment of (p)ppGpp abundance in situations outside of carefully controlled physiological contexts is technically challenging. However, the ability to measure luciferase produced by bacteria during murine infection [70], suggests that it may be possible to monitor expression of the RsFluc reporter inside of a host. In addition, this reporter should facilitate the analysis of (p)ppGpp metabolism in natural isolates and in antibiotic-tolerant persister cells which display intriguing variability in (p)ppGpp abundance [71].

Amino acid availability plays a central role in host-microbe and microbe-microbe interactions. For example, the branched chain amino acids leucine, isoleucine, and valine are essential mammalian amino acids and as such, gut bacteria are a critical source of these molecules [72]. In addition, extracellular amino acid availability/exchange plays a key role in the organization of bacterial communities [73]. Intracellular amino acid availability affects extracellular amino acid availability, either as a consequence of passive and/or active transport across the membrane [74] or potentially as a result of phage lysis [75]. Thus, since (p)ppGpp plays a central role in coordinating intracellular amino acid biosynthesis, (p)ppGpp metabolism likely affects these processes. The RsFluc reporter described here should greatly facilitate investigation of this regulation in physiologically complex contexts.

Methods

Strain construction

Strains were derived from B. subtilis 168 trpC2 except as noted and are listed in S1 Table. Strains were constructed by transformation using conventional methodology and where necessary, media was supplemented with either 100 µg/mL spectinomycin, 10 µg/mL kanamycin, 5 µg/mL chloramphenicol, or 1X MLS. Reporters at sacA were constructed using pSac-cm [76] derived plasmids (S2 Table), confirmed via whole plasmid sequencing via Plasmidsaurus or Genewiz, and sacA integration was confirmed by assaying growth on TSS/glc and nongrowth on TSS sucrose plates. Constructs at amyE were constructed using pDG1730 derived plasmids, confirmed via whole plasmid sequencing, and amyE integration was confirmed by assaying on LB starch plates. Bacitracin-inducible constructs were designed as described previously [77], using PliaI promoter upstream of induced gene (S2 Table). Marker free site-directed mutagenesis of the B. subtilis chromosome was done using pMINIMad2 methodology as described [78], confirming via whole plasmid sequencing and mutated locus sequence by amplification and Sanger sequencing (Genewiz).

(p)ppGpp reporter construction

The various (p)ppGpp reporter strains were constructed by fusing their respective gBlocks (S3 Table) downstream of IPTG-inducible promoter, Phyperspank, and upstream of firefly luciferase gene, using a pSac-cm cloning vector via conventional restriction enzyme and Gibson assembly cloning techniques. Plasmids were sequenced verified and are listed in S2 Table. The vectors were transformed into B. subtilis, selecting on LB Agar supplemented with 5 µg/mL chloramphenicol, and sacA integration was verified using TSS/glc and TSS sucrose plating.

Luminescence measurements

Luminescence was measured in a Tecan Infinite M200 Pro instrument with continuous shaking at 37°C, taking OD600 and luminescence reads every 10 minutes. Cultures were grown from single colonies grown overnight on LB plates at 37°C. Single colonies were picked into 2 mL S7 + CAA (1X MOPS (Teknova), 1.32 mM K2HPO4, 1% glucose, 0.1% glutamic acid, 0.01% casamino acids, 40 µg/mL L-Trp), unless otherwise stated, and grown at 37°C in a roller drum for ~3.5 hours. OD600 measurements were taken to ensure colonies remained in early exponential phase (between OD600 0.3-0.6). The cultures were then diluted to OD600 = 0.05 in 0.5 mL fresh S7 + CAA supplemented with 4.7 mM D-luciferin (Goldbio) and 10 µM IPTG (Goldbio). Note that a spectrophotometer OD600 reading of 0.05 is equivalent to a plate reader reading of ~0.01. Cultures were aliquoted in triplicate in wells amounting 150 µL each in a 96-well white-walled, flat and clear bottom plate (Greiner Bio-One). Media only cells were used for background subtraction.

HPLC-MS nucleotide quantification

Cultures were grown from single colonies grown overnight on LB plates at 37°C. Single colonies were picked into 2 mL S7 + CAA and grown at 37°C in a roller drum for ~3.5 hours. OD600 measurements were taken to ensure colonies remained in early exponential phase (between OD600 0.3-0.6). The cultures were back diluted to OD600 0.05 in 20 mL S7 + CAA supplemented with 4.7mM D-luciferin and 10µM IPTG in baffled flasks. The cultures were incubated at 37°C with shaking in a water bath. At 120, 180, and 300 min, 450 µL were sampled for measuring luminescence and OD600 via Tecan Infinite M200 Pro plate reader, aliquoting 150 µL in triplicate wells. Media only wells were used for background subtraction. Simultaneously, 5 mL of culture were concentrated on 0.2 µm pore (d = 0.47 mm) cellulose acetate membrane filter (Sartorius) via vacuum filtration. The filter was immediately washed with 1 mL ice cold 1M acetic acid solution containing 1 µg/mL 15N-ATP (Sigma) and 1 µg/mL 15N-GTP (Sigma) in a 50 mL conical tube, repeatedly washing the solution over the filter surface using the force of a pipette. Conical tubes were vortexed for 3–5 seconds, and the solution was transferred to 2 mL cryo-vials. Solutions were stored at -80°C. Cold acid nucleotide extractions were performed by thawing samples on ice for 60 minutes, vortexing occasionally. Samples were then re-frozen using liquid nitrogen and lyophilized for 6 hours using a VirTis Benchtop Freeze Dryer. Lyophilized samples were dissolved in 200 µl ice-cold HPLC-grade water, centrifuged at maximum speed for 30 minutes, and clear supernatant was collected for quantification via UHPLC-MS/MS.

UHPLC-MS/MS was performed using an ACQUITY Premier UPLC System coupled with a Waters XEVO TQ-S triple quadrupole mass spectrometer. UPLC was performed on a Hypercarb 2.1x50 mm porous graphitic carbon column (3 μm particle size) using a 10–90% linear gradient of solvent B (0.1% ammonium hydroxide in acetonitrile) in solvent A (0.1 ammonium acetate in water, adjusted to pH 9.5 with ammonium hydroxide) within 10 minutes and a flow rate of 0.3 ml/min. MS/MS analysis was operated in negative ionization mode and a multiple reaction monitoring (MRM) mode was adopted. MassLynx was used to quantify peak intensities.

Amino acid downshift

After 60 min growth in the plate reader, cultures were collected in sterile microcentrifuge tubes, pelleted by centrifugation, and resuspended in equal volume of S7 lacking CAA. Cultures were returned to the plate reader, taking OD600 and luminescence reads every 10 minutes for remainder of assay.

Mupirocin treatment

After 90 min growth in plate reader, mupirocin was added to the cultures at noted concentrations, and OD600 and luminescence measurements were resumed for remainder of assay.

Diauxic shift

Cultures were grown in S7 + CAA (1X MOPS (Teknova), 1.32 mM K2HPO4, 0.1% glutamic acid, 0.01% casamino acids, 40 µg/mL L-Trp) with either 2.5 mg/ml glucose or a mixture of 0.5 mg/mL glucose and 2.0 mg/mL arabinose.

OPP Labeling

Click-iT Plus OPP Protein Synthesis Assay Kit (Invitrogen) was used to label cells with OPP following manufacturer’s instructions. 1000 µL of cells at given time points were transferred to disposable glass tubes. OPP was added to a final concentration of 10 µM. OPP incorporation was performed at 37 °C on a roller drum for 20 min and all subsequent steps were done at RT. Cells were fixed by adding formaldehyde to a final concentration of 1%. Cells were fixed for 30 min, harvested by centrifugation at 15k x g for 3 mins, and permeabilized using 100 µL of 0.5% Triton X-100 in PBS for 15 min. Cells were labelled using 100 µL of 1X Click-iT cocktail for 20 min in the dark. Cells were harvested and washed one time using Click-iT rinse buffer and then re-suspended in 20–100 µL of PBS for imaging.

Fluorescence in situ hybridization (FISH)

yfp FISH probes (S3 Table) were designed and synthesized with CAL Fluor Red 590 Dye (LGC Biosearch Technologies). FISH imaging was performed as described [79] with minor modifications. Briefly, 2 ml cells from mid or late-log cultures grown in S7 + CAA media were collected and fixed with 1% formaldehyde (final concentration) at room temperature for 30 min. The cells were then harvested by centrifugation at 6000 RPM for 3 min at room temperature and washed with 0.02% saline sodium citrate (SSC, Invitrogen). The cell pellets were resuspended in 300 µl MAAM mix (4:1 V:V dilution of methanol to glacial acetic acid) and incubated at -20 °C for 15 minutes, followed by 1X PBS (from 10X PBS, Invitrogen) wash to remove traces of MAAM. Cells were permeabilized in 200µl PBS containing 350 U µl-1 of lysozyme (Epicenter ready-lyse) for 30 min at 37°C. After permeabilization, cells were washed once with 500 µl PBS. The cells were resuspended in 100 µl Stellaris RNA FISH Hybridization Buffer containing 10% formamide and 12.5 µM reconstituted yfp oligo probes for hybridization. The cell-probe mix was incubated in a 30°C water bath overnight. Cells were harvested and washed with 500 µl of reconstituted Stellaris RNA FISH Wash Buffer A containing 10% formamide and incubated at 30°C water bath for 1 hour. The washing step was repeated one more time to remove the excess probe. The cells were harvested and resuspended in 0.5 ml Stellaris RNA FISH Wash Buffer B and incubated for 5 minutes at room temperature. Finally, the cells were harvested and resuspended in 20–40 µl of PBS with 1µl SlowFade Gold Antifade Mountant (Invitrogen). A non-fluorescent control strain, treated with a yfp probe, was used as a control to subtract background and autofluorescence in each channel. Phase contrast and fluorescence images (mCherry (ET Sputter Ex560/40 Dm585 Em630/75)) of bacterial cells immobilized on agarose pads were acquired.

Microscopy

Microscopy was performed on cells immobilized on 1% agarose pads prepared with PBS. Imaging was performed using a Nikon 90i microscope with a Phase contrast objective (CFI Plan Apo Lambda DM × 100 Oil, NA 1.45), an X-Cite light source, a Hamamatsu Orca ER-AG, and the following filter cube: mCherry (ET Sputter Ex560/40 Dm585 Em630/75). Phase contrast and fluorescence images of bacterial cells immobilized on agarose pads were acquired. The image stacks were analyzed in the software Fiji with the help of the MicrobeJ plugin [80]. The straighten and intensity options in the MicrobeJ plugin were used to measure the average fluorescence per pixel within each cell. A non-fluorescent control strain was used to subtract background and autofluorescence in each channel.

Supporting information

S1 Fig. The sequence upstream of luciferase in RSFluc.

Shown is the Phyperspank promoter sequence (red), the lac operator binding sequence (blue) and the D. hafniense ilvE riboswitch gBlock sequence (green), with anti-terminator and terminator sequences bolded and underlined, and the M9 and M11 mutations from Sherlock et al 2018 annotated. In gray, the Shine-Delgarno ribosome binding sequence (RBS). In orange, the 5’ end of the firefly luciferase gene. Restriction enzymes HindIII and BamHI sites bolded.

(TIFF)

pgen.1011691.s001.tiff (432.3KB, tiff)
S2 Fig. Luminescence activity of RSFluc reporter mutants.

Luminescence (RLU/OD600) of: A, RsFluc (blue) and mutant RsFluc construct lacking an aptamer sequence (orange, RS0), B, RsFluc (blue) and M11 mutant RsFluc (green); and C, RsFluc (blue) and M9 mutant RsFluc (pink). Growth (OD600) (black).

(TIFF)

pgen.1011691.s002.tiff (529.7KB, tiff)
S3 Fig. HPLC-MS quantifications of nucleotide levels sampled during growth.

Nucleotide quantifications in the WT (black, JDB4496) and a (p)ppGpp0 background (red, JDB4512) of A) ppGpp, B) GTP, C) guanosine pools, and D) ATP, as analyzed via LC-MS collected at specified intervals.

(TIFF)

pgen.1011691.s003.tiff (431KB, tiff)
S4 Fig. RSFluc transcriptional activity assayed by FISH.

A) Samples of a strain carrying both RSFluc and ilvE-riboswitch-YFP reporters (JDB4623) were collected and analyzed via FISH at specified time points (TP1-TP5: TP1 = 80, TP2 = 120, TP3 = 200, TP4 = 220, TP5 = 240 mins) throughout the luminescence curve (RLU/OD) and imaged via fluorescent microscopy. B) The population distribution of single cell fluorescence at each time point (TP1, n = 202; TP2, n = 333; TP3, n = 481; TP4, n = 315; TP5, n = 197).

(TIFF)

pgen.1011691.s004.tiff (436.3KB, tiff)
S5 Fig. RsFluc response to mupirocin titration.

A, luminescence (RLU/OD600) of RsFluc (JDB4496) at start (T0) of treatment (black) and after 60 mins of treatment, T60 (blue) with varying concentrations of mupirocin. Significance determined by two-way ANOVA with multiple comparison, comparing T0 and T60 under each treatment. 50 ng/mL mupirocin (*) had a p-value of 0.0036 whereas other treatments were not significant. B, growth (OD600) of RsFluc before and after the time of mupirocin addition (dotted line) as treated with DMSO (black), 10 µg/mL (blue), 25 µg/mL (brown), 50 µg/mL (cyan), and 100 µg/mL (green) mupirocin.

(TIFF)

pgen.1011691.s005.tiff (459.1KB, tiff)
S6 Fig. Growth curves of (p)ppGpp synthetase mutants.

Growth (OD600) of wildtype (black, JDB4496), (p)ppGpp0 (red, JDB4512), ∆sasA (green, JDB4515), ∆sasB (orange, JDB4516), and relA-D264G (blue, JDB4741) strains.

(TIFF)

pgen.1011691.s006.tiff (432.8KB, tiff)
S7 Fig. Effect of SasA/B proteins on RsFluc activity.

Luminescence (RLU/OD600) of RsFluc in WT (black, JDB4496) and ∆sasAsasB (gold, JDB4508) backgrounds.

(TIFF)

pgen.1011691.s007.tiff (426.9KB, tiff)
S8 Fig. Synthetases necessary for growth recovery from nutrient downshift.

Luminescence (RLU/OD600) of RsFluc measured post nutrient downshift at T60 (dashed line) in WT (black, JDB4496), ∆sasA (green, JDB4515), ∆sasB (orange, JDB4516), ∆sasAsasB (gold, JDB4508), and relA-D264G (red, JDB4741) backgrounds.

(TIFF)

pgen.1011691.s008.tiff (439.7KB, tiff)
S9 Fig. Growth of (p)ppGpp allosteric synthetase mutants.

Growth (OD600) of wildtype (black, JDB4496), relA-Y200A (fuschia, JDB4528), and sasB-F42A (sky blue, JDB4711) strains.

(TIFF)

pgen.1011691.s009.tiff (421.4KB, tiff)
S10 Fig. Allosteric regulation affects recovery post downshift.

Growth (OD600) post nutrient downshift at T60, (dashed line) in wildtype (black, JDB4496), relA-Y200A (fuschia, JDB4528), and sasB-F42A (sky blue, JDB4711) strains.

(TIFF)

pgen.1011691.s010.tiff (420.1KB, tiff)
S11 Fig. Growth of inducible WT and RelA-D78A.

Growth (OD600) before and after 5 µg/mL bacitracin addition (dashed line) in WT (black, JDB4496), (p)ppGpp0 with inducible WT relA (blue, JDB4675), and (p)ppGpp0 with inducible relA-D78A (green, JDB4676) backgrounds.

(TIFF)

pgen.1011691.s011.tiff (415.2KB, tiff)
S12 Fig. NahA contribution to RsFluc activity.

Luminescence (RLU/OD600) of RsFluc in wildtype (black, JDB4496) and ∆nahA (purple, JDB4567) backgrounds.

(TIFF)

pgen.1011691.s012.tiff (430.4KB, tiff)
S13 Fig. Time points for OPP labeling.

Luminescence (RLU/OD600) of RsFluc in wildtype (blue, JDB4496). Samples were taken at time points TP1 (120 min) and TP2 (240 min).

(TIFF)

pgen.1011691.s013.tiff (418.1KB, tiff)
S1 Table. Strains used.

(DOCX)

pgen.1011691.s014.docx (23.9KB, docx)
S2 Table. Plasmids used.

(DOCX)

pgen.1011691.s015.docx (20.2KB, docx)
S3 Table. Oligonucleotides used.

(DOCX)

pgen.1011691.s016.docx (24.9KB, docx)
S1 Data. Sheet “Figs 1B, S2A, S2B, S2C”.

Raw luminescence data relevant to Figs 1B and 2A2C.Sheet “Figs 1C, S3A, S3C, S3D”. Raw mass spectrometry data relevant to Figs 1C and S3AS3C. Sheet “Fig 1C”. Raw luminescence data relevant to Fig 1C. Sheet “Fig 1D”. Raw luminescence data relevant to Fig 1C. Sheet “S4A Fig”. Raw luminescence data relevant to S4A Fig. Sheet “S4B Fig”. Raw FISH data relevant to S4B Fig. Sheet “Fig 2A”. Raw luminescence data relevant to Fig 2A. Sheet “Fig 2B”. Raw luminescence data relevant to Fig 2B. Sheet “Fig 2C”. Raw luminescence data relevant to Fig 2C. Sheet “Fig 2D”. Raw luminescence data relevant to Fig 2D. Sheet “S5A Fig”. Raw luminescence data relevant to S5A Fig. Sheet “S5B Fig”. Raw luminescence data relevant to S5B Fig. Sheet “Figs 3A, 4A, S6, S9”. Raw luminescence data relevant to Figs 3A, 4A, S6, and S9. Sheet “Figs 3B, 4B, S8, S10”. Raw luminescence data relevant to Figs 3B, 4B, S8, and S10. Sheet “S7 Fig”. Raw luminescence data relevant to S7 Fig. Sheet “Figs 5B, S11”. Raw luminescence data relevant to Figs 5B and S11. Sheet “S12 Fig”. Raw luminescence data relevant to S12 Fig. Sheet “Fig 6A, 6B”. Raw luminescence data relevant to Fig 6A and 6B. Sheet “Fig 7A, 7B”. Raw luminescence data relevant to Fig 7A and 7B. Sheet “Fig 8A”. Raw luminescence data relevant to Fig 8C. Sheet “Fig 8C”. Raw luminescence data relevant to Fig 8C.

(XLSX)

pgen.1011691.s017.xlsx (244KB, xlsx)

Acknowledgments

We acknowledge the contributions of Abigail Whalen to the initial development of the riboswitch reporter and advice from other members of our laboratory. We thank Dale Whittington (UW Mass Spectrometry Center) for assistance with the HPLC-MS analysis. We thank Jonathan Jagodnik for helpful discussions about nucleotide-specific riboswitches and Frederico Gueiros Fihlo for comments on the manuscript.

Data Availability

All Data are in the manuscript and/or Supporting information files

Funding Statement

This work was supported by National Institutes of Health (https://www.nih.gov/) grant R35GM141953 to JD and United States Army Research Office (https://arl.devcom.army.mil/who-we-are/aro/) contract W911NF2110015 to CSH. MH acknowledges support from the Columbia University Graduate Training Program in Microbiology and Immunology (National Institutes of Health Allergy And Infectious Disease grant T32AI106711) and the Training in Cardiovascular Translational Research Training Grant (National Institutes of Health, Heart Lung and Blood Institute grant 5T32HL120826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Anderson BW, Fung DK, Wang JD. Regulatory themes and variations by the stress-signaling nucleotide alarmones (p)ppGpp in bacteria. Annu Rev Genet. 2021;55:115–33. doi: 10.1146/annurev-genet-021821-025827 [DOI] [PubMed] [Google Scholar]
  • 2.Bange G, Brodersen DE, Liuzzi A, Steinchen W. Two P or Not Two P: Understanding Regulation by the Bacterial Second Messengers (p)ppGpp. Annu Rev Microbiol. 2021;75:383–406. doi: 10.1146/annurev-micro-042621-122343 [DOI] [PubMed] [Google Scholar]
  • 3.Schäfer H, Beckert B, Frese CK, Steinchen W, Nuss AM, Beckstette M, et al. The alarmones (p)ppGpp are part of the heat shock response of Bacillus subtilis. PLoS Genet. 2020;16(3):e1008275. doi: 10.1371/journal.pgen.1008275 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Atkinson GC, Tenson T, Hauryliuk V. The RelA/SpoT homolog (RSH) superfamily: distribution and functional evolution of ppGpp synthetases and hydrolases across the tree of life. PLoS One. 2011;6(8):e23479. doi: 10.1371/journal.pone.0023479 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Haseltine WA, Block R. Synthesis of guanosine tetra- and pentaphosphate requires the presence of a codon-specific, uncharged transfer ribonucleic acid in the acceptor site of ribosomes. Proc Natl Acad Sci U S A. 1973;70(5):1564–8. doi: 10.1073/pnas.70.5.1564 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Hogg T, Mechold U, Malke H, Cashel M, Hilgenfeld R. Conformational antagonism between opposing active sites in a bifunctional RelA/SpoT homolog modulates (p)ppGpp metabolism during the stringent response [corrected]. Cell. 2004;117(1):57–68. doi: 10.1016/s0092-8674(04)00260-0 [DOI] [PubMed] [Google Scholar]
  • 7.Nanamiya H, Kasai K, Nozawa A, Yun C-S, Narisawa T, Murakami K, et al. Identification and functional analysis of novel (p)ppGpp synthetase genes in Bacillus subtilis. Mol Microbiol. 2008;67(2):291–304. doi: 10.1111/j.1365-2958.2007.06018.x [DOI] [PubMed] [Google Scholar]
  • 8.Brown A, Fernández IS, Gordiyenko Y, Ramakrishnan V. Ribosome-dependent activation of stringent control. Nature. 2016;534(7606):277–80. doi: 10.1038/nature17675 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Loveland AB, Bah E, Madireddy R, Zhang Y, Brilot AF, Grigorieff N, et al. Ribosome•RelA structures reveal the mechanism of stringent response activation. Elife. 2016;5:e17029. doi: 10.7554/eLife.17029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Takada H, Roghanian M, Caballero-Montes J, Van Nerom K, Jimmy S, Kudrin P, et al. Ribosome association primes the stringent factor Rel for tRNA-dependent locking in the A-site and activation of (p)ppGpp synthesis. Nucleic Acids Res. 2021;49(1):444–57. doi: 10.1093/nar/gkaa1187 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Shyp V, Tankov S, Ermakov A, Kudrin P, English BP, Ehrenberg M, et al. Positive allosteric feedback regulation of the stringent response enzyme RelA by its product. EMBO Rep. 2012;13(9):835–9. doi: 10.1038/embor.2012.106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Steinchen W, Schuhmacher JS, Altegoer F, Fage CD, Srinivasan V, Linne U, et al. Catalytic mechanism and allosteric regulation of an oligomeric (p)ppGpp synthetase by an alarmone. Proc Natl Acad Sci U S A. 2015;112(43):13348–53. doi: 10.1073/pnas.1505271112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Diez S, Hydorn M, Whalen A, Dworkin J. Crosstalk between guanosine nucleotides regulates cellular heterogeneity in protein synthesis during nutrient limitation. PLoS Genet. 2022;18(5):e1009957. doi: 10.1371/journal.pgen.1009957 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Fernandez-Coll L, Cashel M. Contributions of SpoT hydrolase, SpoT synthetase, and RelA synthetase to carbon source diauxic growth transitions in Escherichia coli. Front Microbiol. 2018;9:1802. doi: 10.3389/fmicb.2018.01802 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lee J-W, Park Y-H, Seok Y-J. Rsd balances (p)ppGpp level by stimulating the hydrolase activity of SpoT during carbon source downshift in Escherichia coli. Proc Natl Acad Sci U S A. 2018;115(29):E6845–54. doi: 10.1073/pnas.1722514115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Raskin DM, Judson N, Mekalanos JJ. Regulation of the stringent response is the essential function of the conserved bacterial G protein CgtA in Vibrio cholerae. Proc Natl Acad Sci U S A. 2007;104(11):4636–41. doi: 10.1073/pnas.0611650104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Guiraud P, Germain E, Byrne D, Maisonneuve E. The YmgB-SpoT interaction triggers the stringent response in Escherichia coli. J Biol Chem. 2023;299(12):105429. doi: 10.1016/j.jbc.2023.105429 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Fang M, Bauer CE. Regulation of stringent factor by branched-chain amino acids. Proc Natl Acad Sci U S A. 2018;115(25):6446–51. doi: 10.1073/pnas.1803220115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Roghanian M, Van Nerom K, Takada H, Caballero-Montes J, Tamman H, Kudrin P, et al. (p)ppGpp controls stringent factors by exploiting antagonistic allosteric coupling between catalytic domains. Mol Cell. 2021;81(16):3310–3322.e6. doi: 10.1016/j.molcel.2021.07.026 [DOI] [PubMed] [Google Scholar]
  • 20.Sinha AK, Winther KS. The RelA hydrolase domain acts as a molecular switch for (p)ppGpp synthesis. Commun Biol. 2021;4(1):434. doi: 10.1038/s42003-021-01963-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Pausch P, Abdelshahid M, Steinchen W, Schäfer H, Gratani FL, Freibert S-A, et al. Structural Basis for Regulation of the Opposing (p)ppGpp Synthetase and Hydrolase within the Stringent Response Orchestrator Rel. Cell Rep. 2020;32(11):108157. doi: 10.1016/j.celrep.2020.108157 [DOI] [PubMed] [Google Scholar]
  • 22.Parker DJ, Lalanne J-B, Kimura S, Johnson GE, Waldor MK, Li G-W. Growth-Optimized Aminoacyl-tRNA Synthetase Levels Prevent Maximal tRNA Charging. Cell Syst. 2020;11(2):121–130.e6. doi: 10.1016/j.cels.2020.07.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Fernández-Coll L, Cashel M. Possible Roles for Basal Levels of (p)ppGpp: Growth Efficiency Vs. Surviving Stress. Front Microbiol. 2020;11:592718. doi: 10.3389/fmicb.2020.592718 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Varik V, Oliveira SRA, Hauryliuk V, Tenson T. HPLC-based quantification of bacterial housekeeping nucleotides and alarmone messengers ppGpp and pppGpp. Sci Rep. 2017;7(1):11022. doi: 10.1038/s41598-017-10988-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Patacq C, Chaudet N, Létisse F. Absolute quantification of ppGpp and pppGpp by double-spike isotope dilution ion chromatography-high-resolution mass spectrometry. Anal Chem. 2018;90(18):10715–23. doi: 10.1021/acs.analchem.8b00829 [DOI] [PubMed] [Google Scholar]
  • 26.Zborníková E, Knejzlík Z, Hauryliuk V, Krásný L, Rejman D. Analysis of nucleotide pools in bacteria using HPLC-MS in HILIC mode. Talanta. 2019;205:120161. doi: 10.1016/j.talanta.2019.120161 [DOI] [PubMed] [Google Scholar]
  • 27.Fung DK, Yang J, Stevenson DM, Amador-Noguez D, Wang JD. Small Alarmone Synthetase SasA Expression Leads to Concomitant Accumulation of pGpp, ppApp, and AppppA in Bacillus subtilis. Front Microbiol. 2020;11:2083. doi: 10.3389/fmicb.2020.02083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Sherlock ME, Sudarsan N, Breaker RR. Riboswitches for the alarmone ppGpp expand the collection of RNA-based signaling systems. Proc Natl Acad Sci U S A. 2018;115(23):6052–7. doi: 10.1073/pnas.1720406115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Mirouze N, Prepiak P, Dubnau D. Fluctuations in spo0A transcription control rare developmental transitions in Bacillus subtilis. PLoS Genet. 2011;7(4):e1002048. doi: 10.1371/journal.pgen.1002048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Jagodnik J, Tjaden B, Ross W, Gourse RL. Identification and characterization of RNA binding sites for (p)ppGpp using RNA-DRaCALA. Nucleic Acids Res. 2023;51(2):852–69. doi: 10.1093/nar/gkac1224 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Wendrich TM, Marahiel MA. Cloning and characterization of a relA/spoT homologue from Bacillus subtilis. Mol Microbiol. 1997;26(1):65–79. doi: 10.1046/j.1365-2958.1997.5511919.x [DOI] [PubMed] [Google Scholar]
  • 32.Sørensen MA. Charging levels of four tRNA species in Escherichia coli Rel(+) and Rel(-) strains during amino acid starvation: a simple model for the effect of ppGpp on translational accuracy. J Mol Biol. 2001;307(3):785–98. doi: 10.1006/jmbi.2001.4525 [DOI] [PubMed] [Google Scholar]
  • 33.Zhu M, Dai X. Stringent response ensures the timely adaptation of bacterial growth to nutrient downshift. Nat Commun. 2023;14(1):467. doi: 10.1038/s41467-023-36254-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Dittmar KA, Sorensen MA, Elf J, Ehrenberg M, Pan T. Selective charging of tRNA isoacceptors induced by amino-acid starvation. EMBO Reports. 2005;6(2):151–7. doi: 10.1038/sj.embor.7400341 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Fung DK, Barra JT, Schroeder JW, Ying D, Wang JD. A shared alarmone-GTP switch underlies triggered and spontaneous persistence. bioRxiv. 2020. doi: 2020.03.22.002139 [Google Scholar]
  • 36.Hughes J, Mellows G. Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid. Biochem J. 1978;176(1):305–18. doi: 10.1042/bj1760305 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Cassels R, Oliva B, Knowles D. Occurrence of the regulatory nucleotides ppGpp and pppGpp following induction of the stringent response in staphylococci. J Bacteriol. 1995;177(17):5161–5. doi: 10.1128/jb.177.17.5161-5165.1995 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Traxler MF, Chang D-E, Conway T. Guanosine 3’,5’-bispyrophosphate coordinates global gene expression during glucose-lactose diauxie in Escherichia coli. Proc Natl Acad Sci U S A. 2006;103(7):2374–9. doi: 10.1073/pnas.0510995103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Monod J. Recherches sur la croissance des cultures bactériennes. Paris: Hermann; 1941. [Google Scholar]
  • 40.Anderson BW, Schumacher MA, Yang J, Turdiev A, Turdiev H, Schroeder JW, et al. The nucleotide messenger (p)ppGpp is an anti-inducer of the purine synthesis transcription regulator PurR in Bacillus. Nucleic Acids Res. 2022;50(2):847–66. doi: 10.1093/nar/gkab1281 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Srivatsan A, Han Y, Peng J, Tehranchi AK, Gibbs R, Wang JD, et al. High-precision, whole-genome sequencing of laboratory strains facilitates genetic studies. PLoS Genet. 2008;4(8):e1000139. doi: 10.1371/journal.pgen.1000139 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Radeck J, Kraft K, Bartels J, Cikovic T, Durr F, Emenegger J. The Bacillus BioBrick Box: generation and evaluation of essential genetic building blocks for standardized work with Bacillus subtilis. J Biol Eng. 2013;7(1):29. doi: 10.1186/1754-1611-7-29 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Yang J, Anderson BW, Turdiev A, Turdiev H, Stevenson DM, Amador-Noguez D, et al. The nucleotide pGpp acts as a third alarmone in Bacillus, with functions distinct from those of (p) ppGpp. Nat Commun. 2020;11(1):5388. doi: 10.1038/s41467-020-19166-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Kriel A, Brinsmade SR, Tse JL, Tehranchi AK, Bittner AN, Sonenshein AL, et al. GTP dysregulation in Bacillus subtilis cells lacking (p)ppGpp results in phenotypic amino acid auxotrophy and failure to adapt to nutrient downshift and regulate biosynthesis genes. J Bacteriol. 2014;196(1):189–201. doi: 10.1128/JB.00918-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Diez S, Ryu J, Caban K, Gonzalez RL Jr, Dworkin J. The alarmones (p)ppGpp directly regulate translation initiation during entry into quiescence. Proc Natl Acad Sci U S A. 2020;117(27):15565–72. doi: 10.1073/pnas.1920013117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Scott M, Gunderson CW, Mateescu EM, Zhang Z, Hwa T. Interdependence of cell growth and gene expression: origins and consequences. Science. 2010;330(6007):1099–102. doi: 10.1126/science.1192588 [DOI] [PubMed] [Google Scholar]
  • 47.Gaca AO, Kajfasz JK, Miller JH, Liu K, Wang JD, Abranches J, et al. Basal levels of (p)ppGpp in Enterococcus faecalis: the magic beyond the stringent response. mBio. 2013;4(5):e00646-13. doi: 10.1128/mBio.00646-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Imholz NCE, Noga MJ, van den Broek NJF, Bokinsky G. Calibrating the bacterial growth rate speedometer: a re-evaluation of the relationship between basal ppGpp, growth, and RNA synthesis in Escherichia coli. Front Microbiol. 2020;11:574872. doi: 10.3389/fmicb.2020.574872 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Ababneh QO, Herman JK. RelA inhibits Bacillus subtilis motility and chaining. J Bacteriol. 2015;197(1):128–37. doi: 10.1128/JB.02063-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Trinquier A, Ulmer JE, Gilet L, Figaro S, Hammann P, Kuhn L, et al. tRNA Maturation Defects Lead to Inhibition of rRNA Processing via Synthesis of pppGpp. Molecular Cell. 2019;74(6):1227–38 e3. doi: 10.1016/j.molcel.2019.03.030 [DOI] [PubMed] [Google Scholar]
  • 51.Gallant J, Irr J, Cashel M. The mechanism of amino acid control of guanylate and adenylate biosynthesis. J Biol Chem. 1971;246(18):5812–6. doi: 10.1016/s0021-9258(18)61877-0 [DOI] [PubMed] [Google Scholar]
  • 52.Lopez JM, Dromerick A, Freese E. Response of guanosine 5’-triphosphate concentration to nutritional changes and its significance for Bacillus subtilis sporulation. J Bacteriol. 1981;146(2):605–13. doi: 10.1128/jb.146.2.605-613.1981 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Kriel A, Bittner AN, Kim SH, Liu K, Tehranchi AK, Zou WY, et al. Direct regulation of GTP homeostasis by (p)ppGpp: a critical component of viability and stress resistance. Mol Cell. 2012;48(2):231–41. doi: 10.1016/j.molcel.2012.08.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Tagami K, Nanamiya H, Kazo Y, Maehashi M, Suzuki S, Namba E, et al. Expression of a small (p)ppGpp synthetase, YwaC, in the (p)ppGpp(0) mutant of Bacillus subtilis triggers YvyD-dependent dimerization of ribosome. Microbiologyopen. 2012;1(2):115–34. doi: 10.1002/mbo3.16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Patacq C, Chaudet N, Letisse F. Crucial Role of ppGpp in the Resilience of Escherichia coli to Growth Disruption. mSphere. 2020;5(6):e01132–20. doi: 10.1128/mSphere.01132-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Harshman RB, Yamazaki H. Formation of ppGpp in a relaxed and stringent strain of Escherichia coli during diauxie lag. Biochemistry. 1971;10(21):3980–2. doi: 10.1021/bi00797a027 [DOI] [PubMed] [Google Scholar]
  • 57.Xiao H, Kalman M, Ikehara K, Zemel S, Glaser G, Cashel M. Residual guanosine 3’,5’-bispyrophosphate synthetic activity of relA null mutants can be eliminated by spoT null mutations. J Biol Chem. 1991;266(9):5980–90. [PubMed] [Google Scholar]
  • 58.Solopova A, van Gestel J, Weissing FJ, Bachmann H, Teusink B, Kok J, et al. Bet-hedging during bacterial diauxic shift. Proc Natl Acad Sci U S A. 2014;111(20):7427–32. doi: 10.1073/pnas.1320063111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Steinchen W, Vogt MS, Altegoer F, Giammarinaro PI, Horvatek P, Wolz C, et al. Structural and mechanistic divergence of the small (p)ppGpp synthetases RelP and RelQ. Sci Rep. 2018;8(1):2195. doi: 10.1038/s41598-018-20634-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Dworkin J. Understanding the Stringent Response: Experimental Context Matters. mBio. 2023;14(1):e0340422. doi: 10.1128/mbio.03404-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Gourse RL, Chen AY, Gopalkrishnan S, Sanchez-Vazquez P, Myers A, Ross W. Transcriptional Responses to ppGpp and DksA. Annu Rev Microbiol. 2018;72:163–84. doi: 10.1146/annurev-micro-090817-062444 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Weiss CA, Hoberg JA, Liu K, Tu BP, Winkler WC. Single-Cell Microscopy Reveals That Levels of Cyclic di-GMP Vary among Bacillus subtilis Subpopulations. J Bacteriol. 2019;201(16):e00247-19. doi: 10.1128/JB.00247-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Kviatkovski I, Zhong Q, Vaidya S, Grundling A. Identification of novel genetic factors that regulate c-di-AMP production in Staphylococcus aureus using a riboswitch-based biosensor. mSphere. 2024;2024:e0032124. doi: 10.1128/msphere.00321-24 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Sun Z, Wu R, Zhao B, Zeinert R, Chien P, You M. Live-Cell Imaging of Guanosine Tetra- and Pentaphosphate (p)ppGpp with RNA-based Fluorescent Sensors*. Angew Chem Int Ed Engl. 2021;60(45):24070–4. doi: 10.1002/anie.202111170 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Gaynor EC, Wells DH, MacKichan JK, Falkow S. The Campylobacter jejuni stringent response controls specific stress survival and virulence-associated phenotypes. Mol Microbiol. 2005;56(1):8–27. doi: 10.1111/j.1365-2958.2005.04525.x [DOI] [PubMed] [Google Scholar]
  • 66.Prusa J, Zhu DX, Stallings CL. The stringent response and Mycobacterium tuberculosis pathogenesis. Pathog Dis. 2018;76(5):fty054. doi: 10.1093/femspd/fty054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Dutta NK, Klinkenberg LG, Vazquez M-J, Segura-Carro D, Colmenarejo G, Ramon F, et al. Inhibiting the stringent response blocks Mycobacterium tuberculosis entry into quiescence and reduces persistence. Sci Adv. 2019;5(3):eaav2104. doi: 10.1126/sciadv.aav2104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Schofield WB, Zimmermann-Kogadeeva M, Zimmermann M, Barry NA, Goodman AL. The Stringent Response Determines the Ability of a Commensal Bacterium to Survive Starvation and to Persist in the Gut. Cell Host Microbe. 2018;24(1):120–132.e6. doi: 10.1016/j.chom.2018.06.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Ontai-Brenning A, Hamchand R, Crawford JM, Goodman AL. Gut microbes modulate (p)ppGpp during a time-restricted feeding regimen. mBio. 2023;14(6):e0190723. doi: 10.1128/mbio.01907-23 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Foucault ML, Thomas L, Goussard S, Branchini BR, Grillot-Courvalin C. In vivo bioluminescence imaging for the study of intestinal colonization by Escherichia coli in mice. Appl Environ Microbiol. 2010;76(1):264–74. doi: 10.1128/AEM.01686-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Spira B, Ospino K. Diversity in E. coli (p)ppGpp Levels and Its Consequences. Front Microbiol. 2020;11:1759. doi: 10.3389/fmicb.2020.01759 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.McCann JR, Rawls JF. Essential Amino Acid Metabolites as Chemical Mediators of Host-Microbe Interaction in the Gut. Annu Rev Microbiol. 2023;77:479–97. doi: 10.1146/annurev-micro-032421-111819 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Mee MT, Collins JJ, Church GM, Wang HH. Syntrophic exchange in synthetic microbial communities. Proc Natl Acad Sci U S A. 2014;111(20):E2149–56. doi: 10.1073/pnas.1405641111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.McKinlay JB. Are Bacteria Leaky? Mechanisms of Metabolite Externalization in Bacterial Cross-Feeding. Annu Rev Microbiol. 2023;77:277–97. doi: 10.1146/annurev-micro-032521-023815 [DOI] [PubMed] [Google Scholar]
  • 75.Pherribo GJ, Taga ME. Bacteriophage-mediated lysis supports robust growth of amino acid auxotrophs. ISME J. 2023;17(10):1785–8. doi: 10.1038/s41396-023-01452-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Middleton R, Hofmeister A. New shuttle vectors for ectopic insertion of genes into Bacillus subtilis. Plasmid. 2004;51(3):238–45. doi: 10.1016/j.plasmid.2004.01.006 [DOI] [PubMed] [Google Scholar]
  • 77.Popp PF, Dotzler M, Radeck J, Bartels J, Mascher T. The Bacillus BioBrick Box 2.0: expanding the genetic toolbox for the standardized work with Bacillus subtilis. Sci Rep. 2017;7(1):15058. doi: 10.1038/s41598-017-15107-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Patrick JE, Kearns DB. Laboratory strains of Bacillus subtilis do not exhibit swarming motility. J Bacteriol. 2009;191(22):7129–33. doi: 10.1128/JB.00905-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.McNulty R, Sritharan D, Pahng SH, Meisch JP, Liu S, Brennan MA, et al. Probe-based bacterial single-cell RNA sequencing predicts toxin regulation. Nat Microbiol. 2023;8(5):934–45. doi: 10.1038/s41564-023-01348-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Ducret A, Quardokus EM, Brun YV. MicrobeJ, a tool for high throughput bacterial cell detection and quantitative analysis. Nat Microbiol. 2016;1(7):16077. doi: 10.1038/nmicrobiol.2016.77 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Jue Wang

29 May 2025

PGENETICS-D-25-00454

Analysis of (p)ppGpp metabolism and signaling using a dynamic luminescent reporter

PLOS Genetics

Dear Dr. Dworkin,

Thank you for submitting your manuscript to PLOS Genetics. After careful consideration, we feel that it has merit but does not fully meet PLOS Genetics's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript within 60 days Jul 28 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosgenetics@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgenetics/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

* A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below.

* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Jue D. Wang

Academic Editor

PLOS Genetics

Sean Crosson

Section Editor

PLOS Genetics

Aimée Dudley

Editor-in-Chief

PLOS Genetics

Anne Goriely

Editor-in-Chief

PLOS Genetics

Journal Requirements:

1) Please ensure that the CRediT author contributions listed for every co-author are completed accurately and in full.

At this stage, the following Authors/Authors require contributions: Molly Hydorn, Sathya Narayanan Nagarajan, Elizabeth Fones, Caroline Harwood, and Jonathan Dworkin. Please ensure that the full contributions of each author are acknowledged in the "Add/Edit/Remove Authors" section of our submission form.

The list of CRediT author contributions may be found here: https://journals.plos.org/plosgenetics/s/authorship#loc-author-contributions

2) We ask that a manuscript source file is provided at Revision. Please upload your manuscript file as a .doc, .docx, .rtf or .tex. If you are providing a .tex file, please upload it under the item type u2018LaTeX Source Fileu2019 and leave your .pdf version as the item type u2018Manuscriptu2019.

3) Please upload all main figures as separate Figure files in .tif or .eps format. For more information about how to convert and format your figure files please see our guidelines: 

https://journals.plos.org/plosgenetics/s/figures

4) We notice that your supplementary Figures, and Tables are included in the manuscript file. Please remove them and upload them with the file type 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list.

5) We note that your Data Availability Statement is currently as follows: "All data is contained within the paper". Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data: 

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis..

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

6) Please amend your detailed Financial Disclosure statement. This is published with the article. It must therefore be completed in full sentences and contain the exact wording you wish to be published. Please ensure that the funders and grant numbers match between the Financial Disclosure field and the Funding Information tab in your submission form. Note that the funders must be provided in the same order in both places as well.

- State the initials, alongside each funding source, of each author to receive each grant. For example: "This work was supported by the National Institutes of Health (####### to AM; ###### to CJ) and the National Science Foundation (###### to AM)."

- State what role the funders took in the study. If the funders had no role in your study, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.".

If you did not receive any funding for this study, please simply state: u201cThe authors received no specific funding for this work.u201d

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: In this manuscript, Hydron et al. designed and synthesized a riboswitch-based luciferase reporter for (p)ppGpp, the alarmone that senses amino acid limitation, in Bacillus subtilis. Using a multipronged approach, they first confirmed that the luminescence intensity indeed reflects the (p)ppGpp level in cells. Subsequent, they used this reporter to test various aspects of known (p)ppGpp regulation and the results largely agreed with the literature reports except the absence of decrease in GTP pool when (p)ppGpp increases. Overall, I found the reporter very useful – as the authors mentioned in the discussion, riboswitch reporters have now been increasingly used to measure intracellular concentration of second messengers, and there is a need for more reporters for (p)ppGpp in particular. The potential application in mouse model or in natural bacterial communities is also attractive. The manuscript is thorough; the logic is clear; and the assays well designed and executed. I support the publication of the manuscript in PloS Genetics. There are following comments I have on the technical aspect that the authors may wish to consider in a revised manuscript.

Major Comments:

1. Interpretation of (p)ppGpp synthase deletion effects: The authors use a (p)ppGpp⁰ strain (∆relA∆sasA∆sasB) to show that RsFluc luminescence is strongly reduced (Line 114-117, Figure 1B). While this supports the idea that RsFluc primarily reports (p)ppGpp abundance, it may be worth acknowledging that deletion of relA, sasA, and sasB also broadly alters cell physiology, and global changes in transcription or translation could secondarily affect luciferase expression.

2. Timing of luciferase reporter responses: In Figure 2D, RsFluc luminescence (directly sensing (p)ppGpp) and PurE-luc luminescence (reflecting transcriptional activation) are compared. Since both RsFluc and PurE-luc are luciferase-based reporters, I appreciate that their kinetics can be very rapid. However, because PurE-luc reflects transcriptional activation downstream of (p)ppGpp signaling, whereas RsFluc reflects direct sensing of (p)ppGpp abundance, I would still expect a short but noticeable delay in PurE-luc luminescence relative to RsFluc luminescence. In the current figure, the two signals change almost simultaneously (also mentioned in Line 178). Could the authors comment on the expected timing resolution and whether the sampling interval allows detection of a transcriptional delay? Explicitly commenting on this point would help readers better understand the kinetics of (p)ppGpp signaling versus downstream gene expression.

3. OPP labeling interpretation (Figure 8): The OPP labeling experiments nicely demonstrate a decrease in active translation upon (p)ppGpp accumulation. However, I wonder whether additional controls could strengthen the interpretation. In particular:

● Since OPP labeling efficiency and uptake could vary depending on membrane status or cell stress, did the authors assess cell viability/growth or membrane integrity during the OPP labeling period?

● Given that OPP only measures global nascent protein synthesis, is it possible that selective translation of stress-induced proteins persists even when global rates drop?

● Did the authors check whether OPP labeling efficiency is comparable across conditions (wild-type vs. mutant, stressed vs. unstressed)?

● It would improve the clarity by briefly explaining why the authors picked 120 min and 240 min as TP1 and TP2, respectively.

Minor Comments:

1. Figure 1A: The authors should provide more details about the RsFluc construct either in the figure or the figure legend (e.g., Is the red section in the ppGpp riboswitch a RBS?). Also, there is an unintended break or gap in the line within the riboswitch region and a short red line is present immediately after the riboswitch, which does not seem to correspond to any described feature. Suggest correcting these minor artifacts to improve figure clarity.

2. Line 191: Italicizing sasA and sasB in “... or the combination ΔsasAΔsasB ...”.

3. Line 205-207: “…the magnitude of the increase was not substantially affected, indicating that Rel Y200A likely does not impair synthase activity.”. This statement seems only true during a nutrient downshift but not during normal growth. It would increase the clarity by specifying the condition.

4. Line 283: “... as the mupirocin used in the earlier studies rapidly and strongly simulates (p)ppGpp abundance in <5 min.” There is a small typo where "simulates" should be corrected to "stimulates".

5. It would improve the clarity of the bar graphs if individual data points (e.g., scatter overlay) were shown, allowing readers to assess the variability among replicates.

6. While RsFluc activity closely tracks expected (p)ppGpp dynamics, it is worth noting that (p)ppGpp broadly affects transcription, translation, and metabolic remodeling. I suggest briefly discussing the possibility of these indirect effects on reporter expression, acknowledging that while RsFluc predominantly reflects (p)ppGpp levels, secondary physiological changes could modulate reporter expression to a small extent.

Reviewer #2: This study by Hydorn et. al. develops a riboswitch-based luminescent reporter for the alarmone ppGpp that enables temporal monitoring of levels in live B. subtilis cells. Importantly, besides showing that the reporter works through use of mutants (ppGpp-0 strain, synthase knockouts, rel mutants that affect synthase or hydrolase activity), the researchers were able to observe ppGpp changes in response to amino acid downshift and diauxic shift; use riboswitch variants to separately measure pppGpp and ppGpp levels; correlate the riboswitch reporter to promoters known to be activated by ppGpp. The riboswich-based reporter can be an important tool for other researchers in the field who have sought to study ppGpp dynamics in B. subtilis; however I have the following questions about the study:

1. The researchers do not provide the sequence of their promoter-riboswitch-luciferase reporter construct, they only show a diagram of the construct in Fig. 1A. This will make it difficult for other researchers to make use of this tool.

2. The sequence of the double riboswitch mutant is not provided, and data on this mutant appear to show that it reduces the signal but does not fully disrupt the riboswitch response. Is there a more "null" riboswitch mutant that could be used?

3. Given the strong effect of ppGpp on translation, which the researchers also demonstrate in Figs 8 and S11, they should address whether the drop observed in RLU/OD signal after the peak that typically is at ~240 min may be due to ppGpp decreasing reporter protein synthesis, rather than an actual drop in ppGpp levels. How is the reporter not going to be affected by reduced protein synthesis if its half-life is ~5 mins?

4. Some additional comments: (i) the authors should discuss the ATP and oxygen dependence of the firefly luciferase reporter, which may complicate imaging (ii) "the first time" claim in summary - please see 10.1002/anie.202111170; (iii) "adds them to the 3' carbon" - should be 3' hydroxyl

Reviewer #3: ppGpp is a profoundly important signaling molecule used by diverse bacterial species. In this study, the authors built a biosensor using a ppGpp-sensing riboswitch, thereby allowing them to investigate the relative intracellular dynamics of ppGpp. They validated this biosensor through a collection of mutant strains and growth conditions. Additionally, the authors demonstrated that the ppGpp-sensing reporter fusion could be used to gain insight into the functional role(s) and significance of different synthase and hydrolase enzymes. The manuscript is clear and the data overall supports the authors’ claims. I am confident this manuscript will be well-cited and that other researchers will quickly adopt usage of the ppGpp riboswitch reporter fusion. I have only a few minor comments.

Line 72: remove PMID number.

Lines 473-4: An additional sentence including brief description of culture medium (or a reference) would improve this methods subsection.

Fig 2B: Is it necessary to include the key if the labels will also be included on the x-axis? Also, since “RsFluc-mut” and “M9+M11” refer to the same reporter, choosing one nomenclature will make it easier to understand for the reader. Similarly, a different nomenclature style is used in panel 2D (“ppGpp RS-luciferase”), so coordinating the labels across the figures would help the reader.

Fig 2C: The spike in ppGpp signal as the bacterium switches carbon sources during diauxic growth in interesting; however, since the flattening of the growth curve is essentially a temporary stationary phase, wouldn’t this result imply that a spike in ppGpp would coincide with depletion of the glucose even when a second carbon source had not been included?

Fig 3A: it is not necessary to include any additional experimentation in this figure; however, while the main text points out that the sasA/B double mutant is defective for ppGpp after amino acid downshift, the double mutant is not shown in Fig 3A for comparison, instead it is shown in Fig S5. The data can all be found in the current manuscript, and it therefore does not require any experimental changes. That being said, the location of the data in S5 is a bit odd.

Fig 8A: error measurements are included for the luciferase reporter but not for the growth data. It is a minor comment, but is there a specific reason for that?

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: No: Sequence information and numerical data spreadsheets not found

Reviewer #3: None

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

Figure resubmission:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. If there are other versions of figure files still present in your submission file inventory at resubmission, please replace them with the PACE-processed versions.

Reproducibility:

To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Decision Letter 1

Jue Wang

29 Jul 2025

PGENETICS-D-25-00454R1

Analysis of (p)ppGpp metabolism and signaling using a dynamic luminescent reporter

PLOS Genetics

Dear Dr. Dworkin,

Thank you for submitting your manuscript to PLOS Genetics. After careful consideration, we feel that it has merit but does not fully meet PLOS Genetics's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript within 30 days Aug 28 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosgenetics@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgenetics/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

* A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to formatting updates and technical items listed in the 'Journal Requirements' section below.

* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Jue D. Wang

Academic Editor

PLOS Genetics

Sean Crosson

Section Editor

PLOS Genetics

Aimée Dudley

Editor-in-Chief

PLOS Genetics

Anne Goriely

Editor-in-Chief

PLOS Genetics

Additional Editor Comments :

Hi Jonathan,

As you can see the reviewers are in general happy about your revision. However, if you can address the additional minor comments from reviewer 2, that would be great.

Journal Requirements:

1) Please ensure that the CRediT author contributions listed for every co-author are completed accurately and in full. At this stage, the following Authors/Authors require contributions: Molly Hydorn, Sathya Narayanan Nagarajan, Elizabeth Fones, Caroline Harwood, and Jonathan Dworkin. Please ensure that the full contributions of each author are acknowledged in the "Add/Edit/Remove Authors" section of our submission form. The list of CRediT author contributions may be found here: https://journals.plos.org/plosgenetics/s/authorship#loc-author-contributions   2) We note that your Supplementary Tables files are duplicated on your submission. Please remove them from the main file of the manuscript as they should only be uploaded separately with the file type 'Supporting Information'   3) We do not publish any copyright or trademark symbols that usually accompany proprietary names, eg ©,  ®, or TM  (e.g. next to drug or reagent names). Therefore please remove all instances of trademark/copyright symbols throughout the text, including: - ® : Fluor® on page 21.   4) We have noticed that you have uploaded Supporting Information files, but you have not included a complete list of legends. Please add a full list of legends for your Supporting Information file (compiled raw data copy.xlsx .) after the references list.   5) Please amend your detailed Financial Disclosure statement. This is published with the article. It must therefore be completed in full sentences and contain the exact wording you wish to be published. 1) State the initials, alongside each funding source, of each author to receive each grant. For example: "This work was supported by the National Institutes of Health (####### to AM; ###### to CJ) and the National Science Foundation (###### to AM)." 2) State what role the funders took in the study. If the funders had no role in your study, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 3) If any authors received a salary from any of your funders, please state which authors and which funders..   6) Please provide a completed 'Competing Interests' statement, including any COIs declared by your co-authors. If you have no competing interests to declare, please state "The authors have declared that no competing interests exist". Otherwise please declare all competing interests beginning with the statement "I have read the journal's policy and the authors of this manuscript have the following competing interests:"  

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Reviewers' comments:

Reviewer's Responses to Questions

Reviewer #1: The authors have addressed all my concerns. I recommend the publication of the manuscript.

Reviewer #2: The authors have addressed most of my prior review concerns and questions, however there are some minor aspects that remain:

R2 Point #3: "Second, while (p)ppGpp has a clear inhibitory effect on global protein synthesis (54), this effect would tend to dampen the response of a protein reporter such as luciferase thereby minimizing observed (p)ppGpp-dependent increase in RsFluc activity." The original review point was not about the observed luc signal spike, which this reviewer did not doubt is due to a rise in ppGpp, but instead whether the subsequent DROP in luciferase signal could be due to ppGpp-dependent inhibition of global protein synthesis. Meaning, ppGpp levels might remain high for longer than is observed by the luc reporter. Notably, the ppGpp-0 control cannot rule this out. In the revision, to address this experimentally, the authors have included quantitation of the reporter mRNA by FISH, shown in Fig. S4. However, they need to address the following issues:

(a) Fig. S4A - the x-axis is missing the timepoint values. In particular, without knowing the time difference between TP3 and TP4, it is not possible to evaluate whether the mRNA FISH data make sense with the reporter luminescence data. These results also bear more discussion, because they suggest that ppGpp levels are already low at TP4, which is when luc reporter signal is highest, so there appears to be a time-lag that should be noted. Also, ppGpp levels dropping should not affect the stability of existing full-length transcripts, so depending on the time difference between TP3 and TP4, the observed FISH result may be surprising.

(b) Description of new FISH experiment in the Methods section does not describe how the fluorescence was quantitated. The level of statistical also is not described (how many cells; how many probes).

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

Figure resubmission:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. If there are other versions of figure files still present in your submission file inventory at resubmission, please replace them with the PACE-processed versions.

Reproducibility:

To enhance the reproducibility of your results, we recommend that authors deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Decision Letter 2

Jue Wang

11 Aug 2025

Dear Dr Dworkin,

We are pleased to inform you that your manuscript entitled "Analysis of (p)ppGpp metabolism and signaling using a dynamic luminescent reporter" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Jue D. Wang

Academic Editor

PLOS Genetics

Sean Crosson

Section Editor

PLOS Genetics

Aimée Dudley

Editor-in-Chief

PLOS Genetics

Anne Goriely

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #2: The authors have addressed my remaining feedback in their second revision.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #2: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-25-00454R2

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Acceptance letter

Jue Wang

PGENETICS-D-25-00454R2

Analysis of (p)ppGpp metabolism and signaling using a dynamic luminescent reporter

Dear Dr Dworkin,

We are pleased to inform you that your manuscript entitled "Analysis of (p)ppGpp metabolism and signaling using a dynamic luminescent reporter" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Anita Estes

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. The sequence upstream of luciferase in RSFluc.

    Shown is the Phyperspank promoter sequence (red), the lac operator binding sequence (blue) and the D. hafniense ilvE riboswitch gBlock sequence (green), with anti-terminator and terminator sequences bolded and underlined, and the M9 and M11 mutations from Sherlock et al 2018 annotated. In gray, the Shine-Delgarno ribosome binding sequence (RBS). In orange, the 5’ end of the firefly luciferase gene. Restriction enzymes HindIII and BamHI sites bolded.

    (TIFF)

    pgen.1011691.s001.tiff (432.3KB, tiff)
    S2 Fig. Luminescence activity of RSFluc reporter mutants.

    Luminescence (RLU/OD600) of: A, RsFluc (blue) and mutant RsFluc construct lacking an aptamer sequence (orange, RS0), B, RsFluc (blue) and M11 mutant RsFluc (green); and C, RsFluc (blue) and M9 mutant RsFluc (pink). Growth (OD600) (black).

    (TIFF)

    pgen.1011691.s002.tiff (529.7KB, tiff)
    S3 Fig. HPLC-MS quantifications of nucleotide levels sampled during growth.

    Nucleotide quantifications in the WT (black, JDB4496) and a (p)ppGpp0 background (red, JDB4512) of A) ppGpp, B) GTP, C) guanosine pools, and D) ATP, as analyzed via LC-MS collected at specified intervals.

    (TIFF)

    pgen.1011691.s003.tiff (431KB, tiff)
    S4 Fig. RSFluc transcriptional activity assayed by FISH.

    A) Samples of a strain carrying both RSFluc and ilvE-riboswitch-YFP reporters (JDB4623) were collected and analyzed via FISH at specified time points (TP1-TP5: TP1 = 80, TP2 = 120, TP3 = 200, TP4 = 220, TP5 = 240 mins) throughout the luminescence curve (RLU/OD) and imaged via fluorescent microscopy. B) The population distribution of single cell fluorescence at each time point (TP1, n = 202; TP2, n = 333; TP3, n = 481; TP4, n = 315; TP5, n = 197).

    (TIFF)

    pgen.1011691.s004.tiff (436.3KB, tiff)
    S5 Fig. RsFluc response to mupirocin titration.

    A, luminescence (RLU/OD600) of RsFluc (JDB4496) at start (T0) of treatment (black) and after 60 mins of treatment, T60 (blue) with varying concentrations of mupirocin. Significance determined by two-way ANOVA with multiple comparison, comparing T0 and T60 under each treatment. 50 ng/mL mupirocin (*) had a p-value of 0.0036 whereas other treatments were not significant. B, growth (OD600) of RsFluc before and after the time of mupirocin addition (dotted line) as treated with DMSO (black), 10 µg/mL (blue), 25 µg/mL (brown), 50 µg/mL (cyan), and 100 µg/mL (green) mupirocin.

    (TIFF)

    pgen.1011691.s005.tiff (459.1KB, tiff)
    S6 Fig. Growth curves of (p)ppGpp synthetase mutants.

    Growth (OD600) of wildtype (black, JDB4496), (p)ppGpp0 (red, JDB4512), ∆sasA (green, JDB4515), ∆sasB (orange, JDB4516), and relA-D264G (blue, JDB4741) strains.

    (TIFF)

    pgen.1011691.s006.tiff (432.8KB, tiff)
    S7 Fig. Effect of SasA/B proteins on RsFluc activity.

    Luminescence (RLU/OD600) of RsFluc in WT (black, JDB4496) and ∆sasAsasB (gold, JDB4508) backgrounds.

    (TIFF)

    pgen.1011691.s007.tiff (426.9KB, tiff)
    S8 Fig. Synthetases necessary for growth recovery from nutrient downshift.

    Luminescence (RLU/OD600) of RsFluc measured post nutrient downshift at T60 (dashed line) in WT (black, JDB4496), ∆sasA (green, JDB4515), ∆sasB (orange, JDB4516), ∆sasAsasB (gold, JDB4508), and relA-D264G (red, JDB4741) backgrounds.

    (TIFF)

    pgen.1011691.s008.tiff (439.7KB, tiff)
    S9 Fig. Growth of (p)ppGpp allosteric synthetase mutants.

    Growth (OD600) of wildtype (black, JDB4496), relA-Y200A (fuschia, JDB4528), and sasB-F42A (sky blue, JDB4711) strains.

    (TIFF)

    pgen.1011691.s009.tiff (421.4KB, tiff)
    S10 Fig. Allosteric regulation affects recovery post downshift.

    Growth (OD600) post nutrient downshift at T60, (dashed line) in wildtype (black, JDB4496), relA-Y200A (fuschia, JDB4528), and sasB-F42A (sky blue, JDB4711) strains.

    (TIFF)

    pgen.1011691.s010.tiff (420.1KB, tiff)
    S11 Fig. Growth of inducible WT and RelA-D78A.

    Growth (OD600) before and after 5 µg/mL bacitracin addition (dashed line) in WT (black, JDB4496), (p)ppGpp0 with inducible WT relA (blue, JDB4675), and (p)ppGpp0 with inducible relA-D78A (green, JDB4676) backgrounds.

    (TIFF)

    pgen.1011691.s011.tiff (415.2KB, tiff)
    S12 Fig. NahA contribution to RsFluc activity.

    Luminescence (RLU/OD600) of RsFluc in wildtype (black, JDB4496) and ∆nahA (purple, JDB4567) backgrounds.

    (TIFF)

    pgen.1011691.s012.tiff (430.4KB, tiff)
    S13 Fig. Time points for OPP labeling.

    Luminescence (RLU/OD600) of RsFluc in wildtype (blue, JDB4496). Samples were taken at time points TP1 (120 min) and TP2 (240 min).

    (TIFF)

    pgen.1011691.s013.tiff (418.1KB, tiff)
    S1 Table. Strains used.

    (DOCX)

    pgen.1011691.s014.docx (23.9KB, docx)
    S2 Table. Plasmids used.

    (DOCX)

    pgen.1011691.s015.docx (20.2KB, docx)
    S3 Table. Oligonucleotides used.

    (DOCX)

    pgen.1011691.s016.docx (24.9KB, docx)
    S1 Data. Sheet “Figs 1B, S2A, S2B, S2C”.

    Raw luminescence data relevant to Figs 1B and 2A2C.Sheet “Figs 1C, S3A, S3C, S3D”. Raw mass spectrometry data relevant to Figs 1C and S3AS3C. Sheet “Fig 1C”. Raw luminescence data relevant to Fig 1C. Sheet “Fig 1D”. Raw luminescence data relevant to Fig 1C. Sheet “S4A Fig”. Raw luminescence data relevant to S4A Fig. Sheet “S4B Fig”. Raw FISH data relevant to S4B Fig. Sheet “Fig 2A”. Raw luminescence data relevant to Fig 2A. Sheet “Fig 2B”. Raw luminescence data relevant to Fig 2B. Sheet “Fig 2C”. Raw luminescence data relevant to Fig 2C. Sheet “Fig 2D”. Raw luminescence data relevant to Fig 2D. Sheet “S5A Fig”. Raw luminescence data relevant to S5A Fig. Sheet “S5B Fig”. Raw luminescence data relevant to S5B Fig. Sheet “Figs 3A, 4A, S6, S9”. Raw luminescence data relevant to Figs 3A, 4A, S6, and S9. Sheet “Figs 3B, 4B, S8, S10”. Raw luminescence data relevant to Figs 3B, 4B, S8, and S10. Sheet “S7 Fig”. Raw luminescence data relevant to S7 Fig. Sheet “Figs 5B, S11”. Raw luminescence data relevant to Figs 5B and S11. Sheet “S12 Fig”. Raw luminescence data relevant to S12 Fig. Sheet “Fig 6A, 6B”. Raw luminescence data relevant to Fig 6A and 6B. Sheet “Fig 7A, 7B”. Raw luminescence data relevant to Fig 7A and 7B. Sheet “Fig 8A”. Raw luminescence data relevant to Fig 8C. Sheet “Fig 8C”. Raw luminescence data relevant to Fig 8C.

    (XLSX)

    pgen.1011691.s017.xlsx (244KB, xlsx)
    Attachment

    Submitted filename: Rebuttal.pdf

    pgen.1011691.s019.pdf (72.1KB, pdf)
    Attachment

    Submitted filename: Rebuttal rev 2.docx

    pgen.1011691.s020.docx (15KB, docx)

    Data Availability Statement

    All Data are in the manuscript and/or Supporting information files


    Articles from PLOS Genetics are provided here courtesy of PLOS

    RESOURCES